Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:34422970

Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma.

Chao Ma · Feng Li · Huan Luo

Annals of translational medicine · 2021 doi:10.21037/atm-20-7936

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:34422970
kind
science-record
content_hash
sha256:86bbfc6b932970ecdb3eb4fae8853b2cf889649534991c0dc227f11e94e86337
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:49Z
updated_at
2026-11-01T22:04:32Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma.
doi
10.21037/atm-20-7936
pmid
34422970
authors array · 3 items
[0]
Chao Ma
[1]
Feng Li
[2]
Huan Luo
journal
Annals of translational medicine
year
2021
abstract
BACKGROUND: Lung cancer has been the focus of attention for many researchers in recent years due to its leading contribution to cancer-related death worldwide, with lung adenocarcinoma (LUAD) being the most common histological type. Ferroptosis, a novel iron-dependent form of regulated cell death, can be induced by sorafenib. Emerging evidence shows that triggering ferroptosis has potential as a cancer therapy. This work aimed to build a ferroptosis-related gene signature for predicting the outcome of LUAD. METHODS: The TCGA-LUAD dataset was set as the training cohort, and the GSE72094 and GSE68465 datasets were set as the validation cohorts. Sixty-two ferroptosis-related genes were retrieved from the literature. A univariate Cox regression model was constructed for the training cohort to preliminarily screen for potential prognostic ferroptosis-related genes. A gene signature was generated from a LASSO Cox regression model and assessed with the training and validation cohorts through Kaplan-Meier, Cox, and ROC analyses. In addition, the correlation between the risk score and autophagy-related genes was determined by the Pearson test. Finally, GSEA and immune infiltrating analyses were performed to better study the functional annotation of the signature and the role of each kind of immune cell. RESULTS: A ten-gene signature was constructed from the training cohort and validated in three cohorts by Kaplan-Meier and Cox regression analyses, revealing its independent prognostic value in LUAD. Moreover, a ROC analysis conducted with all cohort data confirmed the predictive ability of the ten-gene signature for LUAD prognosis. A total of 62.85% (308/490) of autophagy-related genes were found to be significantly correlated with risk scores. GSEA detailed the exact pathways related to the gene signature, and immune-infiltrating analyses identified crucial roles for resting mast cells and resting dendritic cells in the prognosis of LUAD. CONCLUSIONS: We identified a novel ferroptosis-related ten-gene signature (PHKG2, PGD, PEBP1, NCOA4, GLS2, CISD1, ATP5G3, ALOX15, ALOX12B, and ACSL3) that can accurately predict LUAD prognosis and is closely linked to resting mast cells and resting dendritic cells.
claims array · 1 item
[0] object · 6 fields
id
claim-data-access
statement
The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:34422970
locator
sections[3] "Cohorts and ferroptosis-related genes" paragraph 2
quote
The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:34422970
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE68465
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE68465
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 7 items
[0] object · 15 fields
id
source:pmid:34422970
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.21037/atm-20-7936
sha256
sha256:e7a68e5752a4517e78a6fce76ead1e5a37d230abd307fe575bf288c108d6382f
bytes
38851
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.21037/atm-20-7936
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC8339871
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE68465
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68465
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE68465
version
null
note
The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.
access_statement_kind
repository_route_statement
sample_accessions array · 462 items
[0]
GSM1672281
[1]
GSM1672282
[2]
GSM1672283
[3]
GSM1672284
[4]
GSM1672285
[5]
GSM1672286
[6]
GSM1672287
[7]
GSM1672288
[8]
GSM1672289
[9]
GSM1672290
[10]
GSM1672291
[11]
GSM1672292
[12]
GSM1672293
[13]
GSM1672294
[14]
GSM1672295
[15]
GSM1672296
[16]
GSM1672297
[17]
GSM1672298
[18]
GSM1672299
[19]
GSM1672300
[20]
GSM1672301
[21]
GSM1672302
[22]
GSM1672303
[23]
GSM1672304
[24]
GSM1672305
[25]
GSM1672306
[26]
GSM1672307
[27]
GSM1672308
[28]
GSM1672309
[29]
GSM1672310
[30]
GSM1672311
[31]
GSM1672312
[32]
GSM1672313
[33]
GSM1672314
[34]
GSM1672315
[35]
GSM1672316
[36]
GSM1672317
[37]
GSM1672318
[38]
GSM1672319
[39]
GSM1672320
[40]
GSM1672321
[41]
GSM1672322
[42]
GSM1672323
[43]
GSM1672324
[44]
GSM1672325
[45]
GSM1672326
[46]
GSM1672327
[47]
GSM1672328
[48]
GSM1672329
[49]
GSM1672330
[50]
GSM1672331
[51]
GSM1672332
[52]
GSM1672333
[53]
GSM1672334
[54]
GSM1672335
[55]
GSM1672336
[56]
GSM1672337
[57]
GSM1672338
[58]
GSM1672339
[59]
GSM1672340
[60]
GSM1672341
[61]
GSM1672342
[62]
GSM1672343
[63]
GSM1672344
[64]
GSM1672345
[65]
GSM1672346
[66]
GSM1672347
[67]
GSM1672348
[68]
GSM1672349
[69]
GSM1672350
[70]
GSM1672351
[71]
GSM1672352
[72]
GSM1672353
[73]
GSM1672354
[74]
GSM1672355
[75]
GSM1672356
[76]
GSM1672357
[77]
GSM1672358
[78]
GSM1672359
[79]
GSM1672360
[80]
GSM1672361
[81]
GSM1672362
[82]
GSM1672363
[83]
GSM1672364
[84]
GSM1672365
[85]
GSM1672366
[86]
GSM1672367
[87]
GSM1672368
[88]
GSM1672369
[89]
GSM1672370
[90]
GSM1672371
[91]
GSM1672372
[92]
GSM1672373
[93]
GSM1672374
[94]
GSM1672375
[95]
GSM1672376
[96]
GSM1672377
[97]
GSM1672378
[98]
GSM1672379
[99]
GSM1672380
[100]
GSM1672381
[101]
GSM1672382
[102]
GSM1672383
[103]
GSM1672384
[104]
GSM1672385
[105]
GSM1672386
[106]
GSM1672387
[107]
GSM1672388
[108]
GSM1672389
[109]
GSM1672390
[110]
GSM1672391
[111]
GSM1672392
[112]
GSM1672393
[113]
GSM1672394
[114]
GSM1672395
[115]
GSM1672396
[116]
GSM1672397
[117]
GSM1672398
[118]
GSM1672399
[119]
GSM1672400
[120]
GSM1672401
[121]
GSM1672402
[122]
GSM1672403
[123]
GSM1672404
[124]
GSM1672405
[125]
GSM1672406
[126]
GSM1672407
[127]
GSM1672408
[128]
GSM1672409
[129]
GSM1672410
[130]
GSM1672411
[131]
GSM1672412
[132]
GSM1672413
[133]
GSM1672414
[134]
GSM1672415
[135]
GSM1672416
[136]
GSM1672417
[137]
GSM1672418
[138]
GSM1672419
[139]
GSM1672420
[140]
GSM1672421
[141]
GSM1672422
[142]
GSM1672423
[143]
GSM1672424
[144]
GSM1672425
[145]
GSM1672426
[146]
GSM1672427
[147]
GSM1672428
[148]
GSM1672429
[149]
GSM1672430
[150]
GSM1672431
[151]
GSM1672432
[152]
GSM1672433
[153]
GSM1672434
[154]
GSM1672435
[155]
GSM1672436
[156]
GSM1672437
[157]
GSM1672438
[158]
GSM1672439
[159]
GSM1672440
[160]
GSM1672441
[161]
GSM1672442
[162]
GSM1672443
[163]
GSM1672444
[164]
GSM1672445
[165]
GSM1672446
[166]
GSM1672447
[167]
GSM1672448
[168]
GSM1672449
[169]
GSM1672450
[170]
GSM1672451
[171]
GSM1672452
[172]
GSM1672453
[173]
GSM1672454
[174]
GSM1672455
[175]
GSM1672456
[176]
GSM1672457
[177]
GSM1672458
[178]
GSM1672459
[179]
GSM1672460
[180]
GSM1672461
[181]
GSM1672462
[182]
GSM1672463
[183]
GSM1672464
[184]
GSM1672465
[185]
GSM1672466
[186]
GSM1672467
[187]
GSM1672468
[188]
GSM1672469
[189]
GSM1672470
[190]
GSM1672471
[191]
GSM1672472
[192]
GSM1672473
[193]
GSM1672474
[194]
GSM1672475
[195]
GSM1672476
[196]
GSM1672477
[197]
GSM1672478
[198]
GSM1672479
[199]
GSM1672480
[200]
GSM1672481
[201]
GSM1672482
[202]
GSM1672483
[203]
GSM1672484
[204]
GSM1672485
[205]
GSM1672486
[206]
GSM1672487
[207]
GSM1672488
[208]
GSM1672489
[209]
GSM1672490
[210]
GSM1672491
[211]
GSM1672492
[212]
GSM1672493
[213]
GSM1672494
[214]
GSM1672495
[215]
GSM1672496
[216]
GSM1672497
[217]
GSM1672498
[218]
GSM1672499
[219]
GSM1672500
[220]
GSM1672501
[221]
GSM1672502
[222]
GSM1672503
[223]
GSM1672504
[224]
GSM1672505
[225]
GSM1672506
[226]
GSM1672507
[227]
GSM1672508
[228]
GSM1672509
[229]
GSM1672510
[230]
GSM1672511
[231]
GSM1672512
[232]
GSM1672513
[233]
GSM1672514
[234]
GSM1672515
[235]
GSM1672516
[236]
GSM1672517
[237]
GSM1672518
[238]
GSM1672519
[239]
GSM1672520
[240]
GSM1672521
[241]
GSM1672522
[242]
GSM1672523
[243]
GSM1672524
[244]
GSM1672525
[245]
GSM1672526
[246]
GSM1672527
[247]
GSM1672528
[248]
GSM1672529
[249]
GSM1672530
[250]
GSM1672531
[251]
GSM1672532
[252]
GSM1672533
[253]
GSM1672534
[254]
GSM1672535
[255]
GSM1672536
[256]
GSM1672537
[257]
GSM1672538
[258]
GSM1672539
[259]
GSM1672540
[260]
GSM1672541
[261]
GSM1672542
[262]
GSM1672543
[263]
GSM1672544
[264]
GSM1672545
[265]
GSM1672546
[266]
GSM1672547
[267]
GSM1672548
[268]
GSM1672549
[269]
GSM1672550
[270]
GSM1672551
[271]
GSM1672552
[272]
GSM1672553
[273]
GSM1672554
[274]
GSM1672555
[275]
GSM1672556
[276]
GSM1672557
[277]
GSM1672558
[278]
GSM1672559
[279]
GSM1672560
[280]
GSM1672561
[281]
GSM1672562
[282]
GSM1672563
[283]
GSM1672564
[284]
GSM1672565
[285]
GSM1672566
[286]
GSM1672567
[287]
GSM1672568
[288]
GSM1672569
[289]
GSM1672570
[290]
GSM1672571
[291]
GSM1672572
[292]
GSM1672573
[293]
GSM1672574
[294]
GSM1672575
[295]
GSM1672576
[296]
GSM1672577
[297]
GSM1672578
[298]
GSM1672579
[299]
GSM1672580
[300]
GSM1672581
[301]
GSM1672582
[302]
GSM1672583
[303]
GSM1672584
[304]
GSM1672585
[305]
GSM1672586
[306]
GSM1672587
[307]
GSM1672588
[308]
GSM1672589
[309]
GSM1672590
[310]
GSM1672591
[311]
GSM1672592
[312]
GSM1672593
[313]
GSM1672594
[314]
GSM1672595
[315]
GSM1672596
[316]
GSM1672597
[317]
GSM1672598
[318]
GSM1672599
[319]
GSM1672600
[320]
GSM1672601
[321]
GSM1672602
[322]
GSM1672603
[323]
GSM1672604
[324]
GSM1672605
[325]
GSM1672606
[326]
GSM1672607
[327]
GSM1672608
[328]
GSM1672609
[329]
GSM1672610
[330]
GSM1672611
[331]
GSM1672612
[332]
GSM1672613
[333]
GSM1672614
[334]
GSM1672615
[335]
GSM1672616
[336]
GSM1672617
[337]
GSM1672618
[338]
GSM1672619
[339]
GSM1672620
[340]
GSM1672621
[341]
GSM1672622
[342]
GSM1672623
[343]
GSM1672624
[344]
GSM1672625
[345]
GSM1672626
[346]
GSM1672627
[347]
GSM1672628
[348]
GSM1672629
[349]
GSM1672630
[350]
GSM1672631
[351]
GSM1672632
[352]
GSM1672633
[353]
GSM1672634
[354]
GSM1672635
[355]
GSM1672636
[356]
GSM1672637
[357]
GSM1672638
[358]
GSM1672639
[359]
GSM1672640
[360]
GSM1672641
[361]
GSM1672642
[362]
GSM1672643
[363]
GSM1672644
[364]
GSM1672645
[365]
GSM1672646
[366]
GSM1672647
[367]
GSM1672648
[368]
GSM1672649
[369]
GSM1672650
[370]
GSM1672651
[371]
GSM1672652
[372]
GSM1672653
[373]
GSM1672654
[374]
GSM1672655
[375]
GSM1672656
[376]
GSM1672657
[377]
GSM1672658
[378]
GSM1672659
[379]
GSM1672660
[380]
GSM1672661
[381]
GSM1672662
[382]
GSM1672663
[383]
GSM1672664
[384]
GSM1672665
[385]
GSM1672666
[386]
GSM1672667
[387]
GSM1672668
[388]
GSM1672669
[389]
GSM1672670
[390]
GSM1672671
[391]
GSM1672672
[392]
GSM1672673
[393]
GSM1672674
[394]
GSM1672675
[395]
GSM1672676
[396]
GSM1672677
[397]
GSM1672678
[398]
GSM1672679
[399]
GSM1672680
[400]
GSM1672681
[401]
GSM1672682
[402]
GSM1672683
[403]
GSM1672684
[404]
GSM1672685
[405]
GSM1672686
[406]
GSM1672687
[407]
GSM1672688
[408]
GSM1672689
[409]
GSM1672690
[410]
GSM1672691
[411]
GSM1672692
[412]
GSM1672693
[413]
GSM1672694
[414]
GSM1672695
[415]
GSM1672696
[416]
GSM1672697
[417]
GSM1672698
[418]
GSM1672699
[419]
GSM1672700
[420]
GSM1672701
[421]
GSM1672702
[422]
GSM1672703
[423]
GSM1672704
[424]
GSM1672705
[425]
GSM1672706
[426]
GSM1672707
[427]
GSM1672708
[428]
GSM1672709
[429]
GSM1672710
[430]
GSM1672711
[431]
GSM1672712
[432]
GSM1672713
[433]
GSM1672714
[434]
GSM1672715
[435]
GSM1672716
[436]
GSM1672717
[437]
GSM1672718
[438]
GSM1672719
[439]
GSM1672720
[440]
GSM1672721
[441]
GSM1672722
[442]
GSM1672723
[443]
GSM1672724
[444]
GSM1672725
[445]
GSM1672726
[446]
GSM1672727
[447]
GSM1672728
[448]
GSM1672729
[449]
GSM1672730
[450]
GSM1672731
[451]
GSM1672732
[452]
GSM1672733
[453]
GSM1672734
[454]
GSM1672735
[455]
GSM1672736
[456]
GSM1672737
[457]
GSM1672738
[458]
GSM1672739
[459]
GSM1672740
[460]
GSM1672741
[461]
GSM1672742
sample_count
462
group_sizes
null
group_sizes_basis
null
platform
96
taxon
Homo sapiens
title
caArray_jacob-00182: Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study
resolution_checked_at
2026-11-01T15:39:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE72094
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72094
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE72094
version
null
note
The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.
access_statement_kind
repository_route_statement
sample_accessions array · 442 items
[0]
GSM1854797
[1]
GSM1854798
[2]
GSM1854799
[3]
GSM1854800
[4]
GSM1854801
[5]
GSM1854802
[6]
GSM1854803
[7]
GSM1854804
[8]
GSM1854805
[9]
GSM1854806
[10]
GSM1854807
[11]
GSM1854808
[12]
GSM1854809
[13]
GSM1854810
[14]
GSM1854811
[15]
GSM1854812
[16]
GSM1854813
[17]
GSM1854814
[18]
GSM1854815
[19]
GSM1854816
[20]
GSM1854817
[21]
GSM1854818
[22]
GSM1854819
[23]
GSM1854820
[24]
GSM1854821
[25]
GSM1854822
[26]
GSM1854823
[27]
GSM1854824
[28]
GSM1854825
[29]
GSM1854826
[30]
GSM1854827
[31]
GSM1854828
[32]
GSM1854829
[33]
GSM1854830
[34]
GSM1854831
[35]
GSM1854832
[36]
GSM1854833
[37]
GSM1854834
[38]
GSM1854835
[39]
GSM1854836
[40]
GSM1854837
[41]
GSM1854838
[42]
GSM1854839
[43]
GSM1854840
[44]
GSM1854841
[45]
GSM1854842
[46]
GSM1854843
[47]
GSM1854844
[48]
GSM1854845
[49]
GSM1854846
[50]
GSM1854847
[51]
GSM1854848
[52]
GSM1854849
[53]
GSM1854850
[54]
GSM1854851
[55]
GSM1854852
[56]
GSM1854853
[57]
GSM1854854
[58]
GSM1854855
[59]
GSM1854856
[60]
GSM1854857
[61]
GSM1854858
[62]
GSM1854859
[63]
GSM1854860
[64]
GSM1854861
[65]
GSM1854862
[66]
GSM1854863
[67]
GSM1854864
[68]
GSM1854865
[69]
GSM1854866
[70]
GSM1854867
[71]
GSM1854868
[72]
GSM1854869
[73]
GSM1854870
[74]
GSM1854871
[75]
GSM1854872
[76]
GSM1854873
[77]
GSM1854874
[78]
GSM1854875
[79]
GSM1854876
[80]
GSM1854877
[81]
GSM1854878
[82]
GSM1854879
[83]
GSM1854880
[84]
GSM1854881
[85]
GSM1854882
[86]
GSM1854883
[87]
GSM1854884
[88]
GSM1854885
[89]
GSM1854886
[90]
GSM1854887
[91]
GSM1854888
[92]
GSM1854889
[93]
GSM1854890
[94]
GSM1854891
[95]
GSM1854892
[96]
GSM1854893
[97]
GSM1854894
[98]
GSM1854895
[99]
GSM1854896
[100]
GSM1854897
[101]
GSM1854898
[102]
GSM1854899
[103]
GSM1854900
[104]
GSM1854901
[105]
GSM1854902
[106]
GSM1854903
[107]
GSM1854904
[108]
GSM1854905
[109]
GSM1854906
[110]
GSM1854907
[111]
GSM1854908
[112]
GSM1854909
[113]
GSM1854910
[114]
GSM1854911
[115]
GSM1854912
[116]
GSM1854913
[117]
GSM1854914
[118]
GSM1854915
[119]
GSM1854916
[120]
GSM1854917
[121]
GSM1854918
[122]
GSM1854919
[123]
GSM1854920
[124]
GSM1854921
[125]
GSM1854922
[126]
GSM1854923
[127]
GSM1854924
[128]
GSM1854925
[129]
GSM1854926
[130]
GSM1854927
[131]
GSM1854928
[132]
GSM1854929
[133]
GSM1854930
[134]
GSM1854931
[135]
GSM1854932
[136]
GSM1854933
[137]
GSM1854934
[138]
GSM1854935
[139]
GSM1854936
[140]
GSM1854937
[141]
GSM1854938
[142]
GSM1854939
[143]
GSM1854940
[144]
GSM1854941
[145]
GSM1854942
[146]
GSM1854943
[147]
GSM1854944
[148]
GSM1854945
[149]
GSM1854946
[150]
GSM1854947
[151]
GSM1854948
[152]
GSM1854949
[153]
GSM1854950
[154]
GSM1854951
[155]
GSM1854952
[156]
GSM1854953
[157]
GSM1854954
[158]
GSM1854955
[159]
GSM1854956
[160]
GSM1854957
[161]
GSM1854958
[162]
GSM1854959
[163]
GSM1854960
[164]
GSM1854961
[165]
GSM1854962
[166]
GSM1854963
[167]
GSM1854964
[168]
GSM1854965
[169]
GSM1854966
[170]
GSM1854967
[171]
GSM1854968
[172]
GSM1854969
[173]
GSM1854970
[174]
GSM1854971
[175]
GSM1854972
[176]
GSM1854973
[177]
GSM1854974
[178]
GSM1854975
[179]
GSM1854976
[180]
GSM1854977
[181]
GSM1854978
[182]
GSM1854979
[183]
GSM1854980
[184]
GSM1854981
[185]
GSM1854982
[186]
GSM1854983
[187]
GSM1854984
[188]
GSM1854985
[189]
GSM1854986
[190]
GSM1854987
[191]
GSM1854988
[192]
GSM1854989
[193]
GSM1854990
[194]
GSM1854991
[195]
GSM1854992
[196]
GSM1854993
[197]
GSM1854994
[198]
GSM1854995
[199]
GSM1854996
[200]
GSM1854997
[201]
GSM1854998
[202]
GSM1854999
[203]
GSM1855000
[204]
GSM1855001
[205]
GSM1855002
[206]
GSM1855003
[207]
GSM1855004
[208]
GSM1855005
[209]
GSM1855006
[210]
GSM1855007
[211]
GSM1855008
[212]
GSM1855009
[213]
GSM1855010
[214]
GSM1855011
[215]
GSM1855012
[216]
GSM1855013
[217]
GSM1855014
[218]
GSM1855015
[219]
GSM1855016
[220]
GSM1855017
[221]
GSM1855018
[222]
GSM1855019
[223]
GSM1855020
[224]
GSM1855021
[225]
GSM1855022
[226]
GSM1855023
[227]
GSM1855024
[228]
GSM1855025
[229]
GSM1855026
[230]
GSM1855027
[231]
GSM1855028
[232]
GSM1855029
[233]
GSM1855030
[234]
GSM1855031
[235]
GSM1855032
[236]
GSM1855033
[237]
GSM1855034
[238]
GSM1855035
[239]
GSM1855036
[240]
GSM1855037
[241]
GSM1855038
[242]
GSM1855039
[243]
GSM1855040
[244]
GSM1855041
[245]
GSM1855042
[246]
GSM1855043
[247]
GSM1855044
[248]
GSM1855045
[249]
GSM1855046
[250]
GSM1855047
[251]
GSM1855048
[252]
GSM1855049
[253]
GSM1855050
[254]
GSM1855051
[255]
GSM1855052
[256]
GSM1855053
[257]
GSM1855054
[258]
GSM1855055
[259]
GSM1855056
[260]
GSM1855057
[261]
GSM1855058
[262]
GSM1855059
[263]
GSM1855060
[264]
GSM1855061
[265]
GSM1855062
[266]
GSM1855063
[267]
GSM1855064
[268]
GSM1855065
[269]
GSM1855066
[270]
GSM1855067
[271]
GSM1855068
[272]
GSM1855069
[273]
GSM1855070
[274]
GSM1855071
[275]
GSM1855072
[276]
GSM1855073
[277]
GSM1855074
[278]
GSM1855075
[279]
GSM1855076
[280]
GSM1855077
[281]
GSM1855078
[282]
GSM1855079
[283]
GSM1855080
[284]
GSM1855081
[285]
GSM1855082
[286]
GSM1855083
[287]
GSM1855084
[288]
GSM1855085
[289]
GSM1855086
[290]
GSM1855087
[291]
GSM1855088
[292]
GSM1855089
[293]
GSM1855090
[294]
GSM1855091
[295]
GSM1855092
[296]
GSM1855093
[297]
GSM1855094
[298]
GSM1855095
[299]
GSM1855096
[300]
GSM1855097
[301]
GSM1855098
[302]
GSM1855099
[303]
GSM1855100
[304]
GSM1855101
[305]
GSM1855102
[306]
GSM1855103
[307]
GSM1855104
[308]
GSM1855105
[309]
GSM1855106
[310]
GSM1855107
[311]
GSM1855108
[312]
GSM1855109
[313]
GSM1855110
[314]
GSM1855111
[315]
GSM1855112
[316]
GSM1855113
[317]
GSM1855114
[318]
GSM1855115
[319]
GSM1855116
[320]
GSM1855117
[321]
GSM1855118
[322]
GSM1855119
[323]
GSM1855120
[324]
GSM1855121
[325]
GSM1855122
[326]
GSM1855123
[327]
GSM1855124
[328]
GSM1855125
[329]
GSM1855126
[330]
GSM1855127
[331]
GSM1855128
[332]
GSM1855129
[333]
GSM1855130
[334]
GSM1855131
[335]
GSM1855132
[336]
GSM1855133
[337]
GSM1855134
[338]
GSM1855135
[339]
GSM1855136
[340]
GSM1855137
[341]
GSM1855138
[342]
GSM1855139
[343]
GSM1855140
[344]
GSM1855141
[345]
GSM1855142
[346]
GSM1855143
[347]
GSM1855144
[348]
GSM1855145
[349]
GSM1855146
[350]
GSM1855147
[351]
GSM1855148
[352]
GSM1855149
[353]
GSM1855150
[354]
GSM1855151
[355]
GSM1855152
[356]
GSM1855153
[357]
GSM1855154
[358]
GSM1855155
[359]
GSM1855156
[360]
GSM1855157
[361]
GSM1855158
[362]
GSM1855159
[363]
GSM1855160
[364]
GSM1855161
[365]
GSM1855162
[366]
GSM1855163
[367]
GSM1855164
[368]
GSM1855165
[369]
GSM1855166
[370]
GSM1855167
[371]
GSM1855168
[372]
GSM1855169
[373]
GSM1855170
[374]
GSM1855171
[375]
GSM1855172
[376]
GSM1855173
[377]
GSM1855174
[378]
GSM1855175
[379]
GSM1855176
[380]
GSM1855177
[381]
GSM1855178
[382]
GSM1855179
[383]
GSM1855180
[384]
GSM1855181
[385]
GSM1855182
[386]
GSM1855183
[387]
GSM1855184
[388]
GSM1855185
[389]
GSM1855186
[390]
GSM1855187
[391]
GSM1855188
[392]
GSM1855189
[393]
GSM1855190
[394]
GSM1855191
[395]
GSM1855192
[396]
GSM1855193
[397]
GSM1855194
[398]
GSM1855195
[399]
GSM1855196
[400]
GSM1855197
[401]
GSM1855198
[402]
GSM1855199
[403]
GSM1855200
[404]
GSM1855201
[405]
GSM1855202
[406]
GSM1855203
[407]
GSM1855204
[408]
GSM1855205
[409]
GSM1855206
[410]
GSM1855207
[411]
GSM1855208
[412]
GSM1855209
[413]
GSM1855210
[414]
GSM1855211
[415]
GSM1855212
[416]
GSM1855213
[417]
GSM1855214
[418]
GSM1855215
[419]
GSM1855216
[420]
GSM1855217
[421]
GSM1855218
[422]
GSM1855219
[423]
GSM1855220
[424]
GSM1855221
[425]
GSM1855222
[426]
GSM1855223
[427]
GSM1855224
[428]
GSM1855225
[429]
GSM1855226
[430]
GSM1855227
[431]
GSM1855228
[432]
GSM1855229
[433]
GSM1855230
[434]
GSM1855231
[435]
GSM1855232
[436]
GSM1855233
[437]
GSM1855234
[438]
GSM1855235
[439]
GSM1855236
[440]
GSM1855237
[441]
GSM1855238
sample_count
442
group_sizes
null
group_sizes_basis
null
platform
15048
taxon
Homo sapiens
title
KRAS mutation-associated gene expression, p53 and STK11 mutations, proliferation and immune surveillance in lung adenocarcinoma
resolution_checked_at
2026-11-01T15:39:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[3] object · 16 fields
id
asset:table:pmid:34422970:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:a8f449ef2de4d59b5d29ccdcf8c3ba1fb5845e9d1e6247113cc0f6a59bf20ac3
bytes
4027
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[10]/table-wrap[1]#t1
version
null
note
Clinical characteristics of patients involved in the study
structure object · 5 fields
pmcid
PMC8339871
section_index
10
section_title
Cohorts’ characteristics
row_count
98
column_count
4
table object · 8 fields
label
Table 1
caption
Clinical characteristics of patients involved in the study
rows array · 98 items
[0] array · 4 items
[0]
Characteristics
[1]
Training cohort (TCGA-LUAD, 500 cases)
[2]
Validation cohort (GSE72094, 442 cases)
[3]
Validation cohort (GSE68465, 443 cases)
[1] array · 4 items
[0]
Age
[1]
[2]
[3]
[2] array · 4 items
[0]
<65
[1]
219 (43.8%)
[2]
115 (26.02%)
[3]
214 (48.31%)
[3] array · 4 items
[0]
≥65
[1]
271 (54.2%)
[2]
306 (69.23%)
[3]
229 (51.69%)
[4] array · 4 items
[0]
Unknown
[1]
10 (2%)
[2]
21 (4.75%)
[3]
0
[5] array · 4 items
[0]
Gender
[1]
[2]
[3]
[6] array · 4 items
[0]
Female
[1]
270 (54%)
[2]
240 (54.3%)
[3]
220 (49.66%)
[7] array · 4 items
[0]
Male
[1]
230 (46%)
[2]
202 (45.7%)
[3]
223 (50.34%)
[8] array · 4 items
[0]
T classification
[1]
[2]
[3]
[9] array · 4 items
[0]
T1
[1]
167 (33.4%)
[2]
NA
[3]
150 (33.86%)
[10] array · 4 items
[0]
T2
[1]
267 (53.4%)
[2]
NA
[3]
251 (56.66%)
[11] array · 4 items
[0]
T3
[1]
45 (9%)
[2]
NA
[3]
28 (6.32%)
[12] array · 4 items
[0]
T4
[1]
18 (3.6%)
[2]
NA
[3]
12 (2.71%)
[13] array · 4 items
[0]
Unknown
[1]
3 (0.6%)
[2]
NA
[3]
2 (0.45%)
[14] array · 4 items
[0]
N classification
[1]
[2]
[3]
[15] array · 4 items
[0]
N0
[1]
324 (64.8%)
[2]
NA
[3]
299 (67.49%)
[16] array · 4 items
[0]
N1
[1]
94 (18.8%)
[2]
NA
[3]
88 (19.86%)
[17] array · 4 items
[0]
N2
[1]
69 (13.8%)
[2]
NA
[3]
53 (11.96%)
[18] array · 4 items
[0]
N3
[1]
2 (0.4%)
[2]
NA
[3]
0
[19] array · 4 items
[0]
Unknown
[1]
11 (2.2%)
[2]
NA
[3]
3 (0.68%)
[20] array · 4 items
[0]
M classification
[1]
[2]
[3]
[21] array · 4 items
[0]
M0
[1]
332 (66.4%)
[2]
NA
[3]
NA
[22] array · 4 items
[0]
M1
[1]
24 (4.8%)
[2]
NA
[3]
NA
[23] array · 4 items
[0]
Unknown
[1]
144 (28.8%)
[2]
NA
[3]
NA
[24] array · 4 items
[0]
Tumor stage
[1]
[2]
[3]
[25] array · 4 items
[0]
Stage I
[1]
268 (53.6%)
[2]
265 (59.95%)
[3]
NA
[26] array · 4 items
[0]
Stage II
[1]
119 (23.8%)
[2]
69 (15.61%)
[3]
NA
[27] array · 4 items
[0]
Stage III
[1]
80 (16%)
[2]
63 (14.25%)
[3]
NA
[28] array · 4 items
[0]
Stage IV
[1]
25 (5%)
[2]
17 (3.85%)
[3]
NA
[29] array · 4 items
[0]
Unknown
[1]
8 (1.6%)
[2]
28 (6.33%)
[3]
NA
[30] array · 4 items
[0]
Race
[1]
[2]
[3]
[31] array · 4 items
[0]
White
[1]
386 (77.2%)
[2]
399 (90.27%)
[3]
295 (66.59%)
[32] array · 4 items
[0]
Black or African American
[1]
52 (10.4%)
[2]
13 (2.94%)
[3]
12 (2.71%)
[33] array · 4 items
[0]
American Indian or Alaska Native
[1]
1 (0.2%)
[2]
0
[3]
1 (0.23%)
[34] array · 4 items
[0]
Asian
[1]
7 (1.4%)
[2]
3 (0.68%)
[3]
6 (1.35%)
[35] array · 4 items
[0]
Unknown
[1]
54 (10.8%)
[2]
27 (6.11%)
[3]
129 (29.12%)
[36] array · 4 items
[0]
Ethnicity
[1]
[2]
[3]
[37] array · 4 items
[0]
Hispanic or Latino
[1]
7 (1.4%)
[2]
10 (2.26%)
[3]
NA
[38] array · 4 items
[0]
Not Hispanic or Latino
[1]
381 (76.2%)
[2]
402 (90.95%)
[3]
NA
[39] array · 4 items
[0]
Unknown
[1]
112 (22.4%)
[2]
30 (6.79%)
[3]
NA
[40] array · 4 items
[0]
Tobacco smoking history
[1]
[2]
[3]
[41] array · 4 items
[0]
Ever
[1]
415 (83%)
[2]
335 (75.79%)
[3]
300 (67.72%)
[42] array · 4 items
[0]
Never
[1]
71 (14.2%)
[2]
33 (7.47%)
[3]
49 (11.06%)
[43] array · 4 items
[0]
Unknown
[1]
14 (2.8%)
[2]
74 (16.74%)
[3]
94 (21.22%)
[44] array · 4 items
[0]
Number pack-years smoked
[1]
[2]
[3]
[45] array · 4 items
[0]
<30
[1]
115 (23%)
[2]
NA
[3]
NA
[46] array · 4 items
[0]
≥30
[1]
227 (45.4%)
[2]
NA
[3]
NA
[47] array · 4 items
[0]
Unknown
[1]
158 (31.6%)
[2]
NA
[3]
NA
[48] array · 4 items
[0]
Radiation therapy
[1]
[2]
[3]
[49] array · 4 items
[0]
Yes
[1]
58 (11.6%)
[2]
NA
[3]
65 (14.67%)
[50] array · 4 items
[0]
No
[1]
361 (72.2%)
[2]
NA
[3]
364 (82.17%)
[51] array · 4 items
[0]
Unknown
[1]
81 (16.2%)
[2]
NA
[3]
14 (3.16%)
[52] array · 4 items
[0]
Chemotherapy
[1]
[2]
[3]
[53] array · 4 items
[0]
Yes
[1]
NA
[2]
NA
[3]
89 (20.09%)
[54] array · 4 items
[0]
No
[1]
NA
[2]
NA
[3]
341 (76.98%)
[55] array · 4 items
[0]
Unknown
[1]
NA
[2]
NA
[3]
13 (2.93%)
[56] array · 3 items
[0]
Additional pharmaceutical therapy
[1]
[2]
[57] array · 4 items
[0]
Yes
[1]
61 (12.2%)
[2]
NA
[3]
NA
[58] array · 4 items
[0]
No
[1]
68 (13.6%)
[2]
NA
[3]
NA
[59] array · 4 items
[0]
Unknown
[1]
371 (74.2%)
[2]
NA
[3]
NA
[60] array · 4 items
[0]
Additional radiation therapy
[1]
[2]
[3]
[61] array · 4 items
[0]
Yes
[1]
61 (12.2%)
[2]
NA
[3]
NA
[62] array · 4 items
[0]
No
[1]
71 (14.2%)
[2]
NA
[3]
NA
[63] array · 4 items
[0]
Unknown
[1]
368 (73.6%)
[2]
NA
[3]
NA
[64] array · 4 items
[0]
EGFR mutation
[1]
[2]
[3]
[65] array · 4 items
[0]
Yes
[1]
80 (16%)
[2]
47 (10.63%)
[3]
NA
[66] array · 4 items
[0]
No
[1]
191 (38.2%)
[2]
395 (89.37%)
[3]
NA
[67] array · 4 items
[0]
Unknown
[1]
229 (45.8%)
[2]
0
[3]
NA
[68] array · 4 items
[0]
KRAS mutation
[1]
[2]
[3]
[69] array · 4 items
[0]
Yes
[1]
23 (4.6%)
[2]
154 (34.84%)
[3]
NA
[70] array · 4 items
[0]
No
[1]
39 (7.8%)
[2]
288 (65.16%)
[3]
NA
[71] array · 4 items
[0]
Unknown
[1]
438 (87.6%)
[2]
0
[3]
NA
[72] array · 4 items
[0]
STK11 mutation
[1]
[2]
[3]
[73] array · 4 items
[0]
Yes
[1]
NA
[2]
68 (15.38%)
[3]
NA
[74] array · 4 items
[0]
No
[1]
NA
[2]
374 (84.62%)
[3]
NA
[75] array · 4 items
[0]
TP53 mutation
[1]
[2]
[3]
[76] array · 4 items
[0]
Yes
[1]
NA
[2]
111 (25.11%)
[3]
NA
[77] array · 4 items
[0]
No
[1]
NA
[2]
331 (74.89%)
[3]
NA
[78] array · 4 items
[0]
EML4-ALK mutation
[1]
[2]
[3]
[79] array · 4 items
[0]
Yes
[1]
34 (6.8%)
[2]
NA
[3]
NA
[80] array · 4 items
[0]
No
[1]
207 (41.4%)
[2]
NA
[3]
NA
[81] array · 4 items
[0]
Unknown
[1]
259 (51.8%)
[2]
NA
[3]
NA
[82] array · 3 items
[0]
Tumor intermediate dimension
[1]
[2]
[83] array · 4 items
[0]
<1
[1]
287 (57.4%)
[2]
NA
[3]
NA
[84] array · 4 items
[0]
≥1
[1]
88 (17.6%)
[2]
NA
[3]
NA
[85] array · 4 items
[0]
Unknown
[1]
125 (25%)
[2]
NA
[3]
NA
[86] array · 4 items
[0]
Location in lung parenchyma
[1]
[2]
[3]
[87] array · 4 items
[0]
Central lung
[1]
62 (12.4%)
[2]
NA
[3]
NA
[88] array · 4 items
[0]
Peripheral lung
[1]
118 (23.6%)
[2]
NA
[3]
NA
[89] array · 4 items
[0]
Unknown
[1]
320 (64%)
[2]
NA
[3]
NA
[90] array · 3 items
[0]
Person neoplasm cancer status
[1]
[2]
[91] array · 4 items
[0]
With tumor
[1]
134 (26.8%)
[2]
NA
[3]
NA
[92] array · 4 items
[0]
Tumor free
[1]
243 (48.6%)
[2]
NA
[3]
NA
[93] array · 4 items
[0]
Unknown
[1]
123 (24.6%)
[2]
NA
[3]
NA
[94] array · 4 items
[0]
Vital status
[1]
[2]
[3]
[95] array · 4 items
[0]
Alive
[1]
318 (63.6%)
[2]
298 (67.42%)
[3]
207 (46.73%)
[96] array · 4 items
[0]
Dead
[1]
182 (36.4%)
[2]
122 (27.6%)
[3]
236 (53.27%)
[97] array · 4 items
[0]
Unknown
[1]
0
[2]
22 (4.98%)
[3]
NA
locator
section[10]/table-wrap[1]#t1
[4] object · 16 fields
id
asset:table:pmid:34422970:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:af60f9de62ac4bb361a71c47a9ed9536397621443f7d9a8296ad931a5388110f
bytes
1757
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[1]#t2
version
null
note
14 ferroptosis-related potential prognostic genes generated from the training cohort
structure object · 5 fields
pmcid
PMC8339871
section_index
11
section_title
Identification of a prognostic ferroptosis-related gene signature from the training cohort
row_count
16
column_count
6
table object · 8 fields
label
Table 2
caption
14 ferroptosis-related potential prognostic genes generated from the training cohort
rows array · 16 items
[0] array · 5 items
[0]
Gene symbol
[1]
Description
[2]
HR
[3]
95% confidence interval
[4]
P value
[1] array · 2 items
[0]
Lower
[1]
Upper
[2] array · 6 items
[0]
PEBP1
[1]
Phosphatidylethanolamine-Binding Protein 1
[2]
0.603658936
[3]
0.464865289
[4]
0.78389185
[5]
0.000152746
[3] array · 6 items
[0]
ACSL3
[1]
Acyl-CoA Synthetase Long-Chain Family Member 3
[2]
1.435108616
[3]
1.157210163
[4]
1.779743045
[5]
0.001003251
[4] array · 6 items
[0]
GLS2
[1]
Glutaminase 2
[2]
0.356469987
[3]
0.176890046
[4]
0.71836067
[5]
0.003911814
[5] array · 6 items
[0]
GCLC
[1]
Glutamate-Cysteine Ligase Catalytic Subunit
[2]
1.135847381
[3]
1.034367787
[4]
1.24728292
[5]
0.007639188
[6] array · 6 items
[0]
SLC7A11
[1]
Solute Carrier Family 7 Member 11
[2]
1.137868621
[3]
1.023951703
[4]
1.264459052
[5]
0.016406631
[7] array · 6 items
[0]
PHKG2
[1]
Phosphorylase Kinase Catalytic Subunit Gamma 2
[2]
0.69374619
[3]
0.511654438
[4]
0.940642238
[5]
0.018577862
[8] array · 6 items
[0]
PGD
[1]
Phosphogluconate Dehydrogenase
[2]
1.177966423
[3]
1.02132216
[4]
1.358635842
[5]
0.02446422
[9] array · 6 items
[0]
CISD1
[1]
CDGSH Iron Sulfur Domain 1
[2]
1.403301444
[3]
1.041497232
[4]
1.890792296
[5]
0.025931782
[10] array · 6 items
[0]
ALOX12B
[1]
Arachidonate 12-Lipoxygenase, 12R Type
[2]
1.528527805
[3]
1.03748207
[4]
2.251988076
[5]
0.031866869
[11] array · 6 items
[0]
DPP4
[1]
Dipeptidyl Peptidase 4
[2]
0.911077238
[3]
0.836744384
[4]
0.992013511
[5]
0.031983077
[12] array · 6 items
[0]
ALOX15
[1]
Arachidonate 15-Lipoxygenase
[2]
0.857033797
[3]
0.740142144
[4]
0.992386306
[5]
0.039196308
[13] array · 6 items
[0]
ATP5G3
[1]
ATP Synthase Membrane Subunit C Locus 3
[2]
1.311553769
[3]
1.01163069
[4]
1.700396506
[5]
0.040633369
[14] array · 6 items
[0]
ABCC1
[1]
ATP Binding Cassette Subfamily C Member 1
[2]
1.23437377
[3]
1.007318781
[4]
1.512608156
[5]
0.042328557
[15] array · 6 items
[0]
NCOA4
[1]
Nuclear Receptor Coactivator 4
[2]
0.776056577
[3]
0.603024235
[4]
0.998738982
[5]
0.048865024
locator
section[11]/table-wrap[1]#t2
[5] object · 16 fields
id
asset:table:pmid:34422970:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:e371ce4db74b4bb3c542daa5d9d067e9016cd44760ffb44ffd99c1d8d8179dd1
bytes
902
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[2]#t3
version
null
note
10 ferroptosis-related prognostic genes obtained from LASSO Cox regression model
structure object · 5 fields
pmcid
PMC8339871
section_index
11
section_title
Identification of a prognostic ferroptosis-related gene signature from the training cohort
row_count
11
column_count
3
table object · 8 fields
label
Table 3
caption
10 ferroptosis-related prognostic genes obtained from LASSO Cox regression model
rows array · 11 items
[0] array · 3 items
[0]
Gene symbol
[1]
Description
[2]
Risk coefficient
[1] array · 3 items
[0]
PHKG2
[1]
Phosphorylase Kinase Catalytic Subunit Gamma 2
[2]
−0.376487238
[2] array · 3 items
[0]
PGD
[1]
Phosphogluconate Dehydrogenase
[2]
0.027750809
[3] array · 3 items
[0]
PEBP1
[1]
Phosphatidylethanolamine Binding Protein 1
[2]
−0.369553219
[4] array · 3 items
[0]
NCOA4
[1]
Nuclear Receptor Coactivator 4
[2]
−0.498545244
[5] array · 3 items
[0]
GLS2
[1]
Glutaminase 2
[2]
−0.399525822
[6] array · 3 items
[0]
CISD1
[1]
CDGSH Iron Sulfur Domain 1
[2]
0.313326653
[7] array · 3 items
[0]
ATP5G3
[1]
ATP Synthase Membrane Subunit C Locus 3
[2]
0.019018653
[8] array · 3 items
[0]
ALOX15
[1]
Arachidonate 15-Lipoxygenase
[2]
−0.049973524
[9] array · 3 items
[0]
ALOX12B
[1]
Arachidonate 12-Lipoxygenase, 12R Type
[2]
0.323899465
[10] array · 3 items
[0]
ACSL3
[1]
Acyl-CoA Synthetase Long Chain Family Member 3
[2]
0.246495026
locator
section[11]/table-wrap[2]#t3
[6] object · 16 fields
id
asset:table:pmid:34422970:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:f958976cfdaae725dac9f3b89b533f2f1ab7b0b3a4a3044246dc661fcd3105ff
bytes
7789
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#t4
version
null
note
Univariate analysis and multivariate analysis of the correlation of gene signature risk score with outcomes among lung adenocarcinoma patients in three cohorts
structure object · 5 fields
pmcid
PMC8339871
section_index
12
section_title
Prognostic ability of the ten-gene signature
row_count
67
column_count
10
table object · 8 fields
label
Table 4
caption
Univariate analysis and multivariate analysis of the correlation of gene signature risk score with outcomes among lung adenocarcinoma patients in three cohorts
rows array · 67 items
[0] array · 4 items
[0]
Variable
[1]
Univariate Cox analysis
[2]
[3]
Multivariate Cox analysis
[1] array · 8 items
[0]
coef
[1]
HR (95% CI)
[2]
z
[3]
P value
[4]
coef
[5]
HR (95% CI)
[6]
z
[7]
P value
[2] array · 10 items
[0]
TCGA-LUAD (overall survival)^
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[3] array · 10 items
[0]
Gender (male vs. female)
[1]
0.048
[2]
1.05 (0.784–1.4)
[3]
0.322
[4]
7.47E-01
[5]
[6]
[7]
[8]
[9]
[4] array · 10 items
[0]
Age
[1]
0.00816
[2]
1.01 (0.993–1.02)
[3]
1.05
[4]
2.94E-01
[5]
[6]
[7]
[8]
[9]
[5] array · 10 items
[0]
Tumor stage II (vs. stage I)
[1]
0.905
[2]
2.47 (1.72–3.56)
[3]
4.87
[4]
1.09E-06*
[5]
[6]
1.32
[7]
3.75 (1.44–9.8)
[8]
2.7
[9]
6.93E-03
[6] array · 10 items
[0]
Tumor stage III (vs. stage I)
[1]
1.25
[2]
3.49 (2.38–5.12)
[3]
6.4
[4]
1.51E-10*
[5]
[6]
0.455
[7]
1.58 (0.445–5.59)
[8]
0.705
[9]
4.81E-01
[7] array · 10 items
[0]
Tumor stage IV (vs. stage I)
[1]
1.34
[2]
3.82 (2.2–6.62)
[3]
4.76
[4]
1.92E-06*
[5]
[6]
−0.107
[7]
0.899 (0.255–3.17)
[8]
−0.166
[9]
8.68E-01
[8] array · 10 items
[0]
Tobacco smoking history (ever vs. never)
[1]
−0.127
[2]
0.88 (0.583–1.33)
[3]
−0.605
[4]
5.45E-01
[5]
[6]
[7]
[8]
[9]
[9] array · 10 items
[0]
Number pack years smoked
[1]
0.00327
[2]
1 (0.996–1.01)
[3]
0.938
[4]
3.48E-01
[5]
[6]
[7]
[8]
[9]
[10] array · 10 items
[0]
Race (White vs. non-White)
[1]
0.36
[2]
1.43 (0.875–2.34)
[3]
1.43
[4]
1.53E-01
[5]
[6]
[7]
[8]
[9]
[11] array · 10 items
[0]
Ethnicity (Hispanic or Latino vs. Non-Hispanic or Latino)
[1]
0.387
[2]
1.47 (0.466–4.65)
[3]
0.658
[4]
5.10E-01
[5]
[6]
[7]
[8]
[9]
[12] array · 10 items
[0]
Tumor intermediate dimension
[1]
0.441
[2]
1.55 (0.922–2.62)
[3]
1.65
[4]
9.80E-02
[5]
[6]
[7]
[8]
[9]
[13] array · 10 items
[0]
Radiation therapy (yes vs. no)
[1]
0.763
[2]
2.14 (1.44–3.19)
[3]
3.76
[4]
1.73E-04*
[5]
[6]
0.446
[7]
1.56 (0.415–5.88)
[8]
0.66
[9]
5.09E-01
[14] array · 10 items
[0]
Additional pharmaceutical therapy (yes vs. no)
[1]
−0.502
[2]
0.605 (0.382–0.959)
[3]
−2.14
[4]
3.26E-02*
[5]
[6]
−1.03
[7]
0.356 (0.158–0.8)
[8]
−2.5
[9]
1.25E-02*
[15] array · 10 items
[0]
Additional radiation therapy (yes vs. no)
[1]
−0.0153
[2]
0.985 (0.625–1.55)
[3]
−0.0661
[4]
9.47E-01
[5]
[6]
[7]
[8]
[9]
[16] array · 10 items
[0]
Location in lung parenchyma (central lung vs. peripheral lung)
[1]
0.0908
[2]
1.09 (0.684–1.75)
[3]
0.378
[4]
7.06E-01
[5]
[6]
[7]
[8]
[9]
[17] array · 10 items
[0]
KRAS mutation (yes vs. no)
[1]
0.492
[2]
1.63 (0.672–3.98)
[3]
1.08
[4]
2.78E-01
[5]
[6]
[7]
[8]
[9]
[18] array · 10 items
[0]
EGFR mutation (yes vs. no)
[1]
0.268
[2]
1.31 (0.828–2.06)
[3]
1.15
[4]
2.50E-01
[5]
[6]
[7]
[8]
[9]
[19] array · 10 items
[0]
EML4-ALK mutation (yes vs. no)
[1]
0.592
[2]
1.81 (1.01–3.24)
[3]
1.98
[4]
4.73E-02*
[5]
[6]
1.18
[7]
3.25 (1.22–8.63)
[8]
2.36
[9]
1.84E-02*
[20] array · 10 items
[0]
Risk score
[1]
1.22
[2]
3.39 (2.49–4.62)
[3]
7.76
[4]
8.78E-15*
[5]
[6]
1.99
[7]
7.32 (2.88–18.6)
[8]
4.18
[9]
2.94E-05*
[21] array · 10 items
[0]
TCGA-LUAD (progression-free survival)#
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[22] array · 10 items
[0]
Gender (male vs. female)
[1]
0.07
[2]
1.07 (0.815–1.41)
[3]
0.499
[4]
6.17E-01
[5]
[6]
[7]
[8]
[9]
[23] array · 10 items
[0]
Age
[1]
−0.000998
[2]
0.999 (0.985–1.01)
[3]
−0.141
[4]
8.88E-01
[5]
[6]
[7]
[8]
[9]
[24] array · 10 items
[0]
Tumor stage II (vs. stage I)
[1]
0.798
[2]
2.22 (1.61–3.07)
[3]
4.85
[4]
1.22E-06*
[5]
[6]
1.2
[7]
3.33 (1.92–5.78)
[8]
4.28
[9]
1.88E-05*
[25] array · 10 items
[0]
Tumor stage III (vs. stage I)
[1]
0.709
[2]
2.03 (1.38–2.99)
[3]
3.61
[4]
3.10E-04*
[5]
[6]
0.95
[7]
2.59 (1.31–5.11)
[8]
2.73
[9]
6.25E-03*
[26] array · 10 items
[0]
Tumor stage IV (vs. stage I)
[1]
0.849
[2]
2.34 (1.32–4.13)
[3]
2.93
[4]
3.40E-03*
[5]
[6]
0.828
[7]
2.29 (0.979–5.35)
[8]
1.91
[9]
5.60E-02
[27] array · 10 items
[0]
Tobacco smoking history (ever vs. never)
[1]
−0.0557
[2]
0.946 (0.637–1.4)
[3]
−0.276
[4]
7.82E-01
[5]
[6]
[7]
[8]
[9]
[28] array · 10 items
[0]
Number pack years smoked
[1]
−0.000552
[2]
0.999 (0.993–1.01)
[3]
−0.165
[4]
8.69E-01
[5]
[6]
[7]
[8]
[9]
[29] array · 10 items
[0]
Race (White vs. non-White)
[1]
0.0557
[2]
1.06 (0.703–1.59)
[3]
0.268
[4]
7.89E-01
[5]
[6]
[7]
[8]
[9]
[30] array · 10 items
[0]
Ethnicity (Hispanic or Latino vs. non-Hispanic or Latino)
[1]
0.291
[2]
1.34 (0.495–3.62)
[3]
0.574
[4]
5.66E-01
[5]
[6]
[7]
[8]
[9]
[31] array · 10 items
[0]
Tumor intermediate dimension
[1]
0.328
[2]
1.39 (0.84–2.29)
[3]
1.28
[4]
2.01E-01
[5]
[6]
[7]
[8]
[9]
[32] array · 10 items
[0]
Radiation therapy (yes vs. no)
[1]
0.707
[2]
2.03 (1.42–2.89)
[3]
3.92
[4]
9.01E-05*
[5]
[6]
0.432
[7]
1.54 (0.829–2.86)
[8]
1.37
[9]
1.72E-01
[33] array · 10 items
[0]
Additional pharmaceutical therapy (yes vs. no)
[1]
0.27
[2]
1.31 (0.914–1.88)
[3]
1.47
[4]
1.41E-01
[5]
[6]
[7]
[8]
[9]
[34] array · 10 items
[0]
Additional radiation therapy (yes vs. no)
[1]
0.16
[2]
1.17 (0.825–1.67)
[3]
0.89
[4]
3.73E-01
[5]
[6]
[7]
[8]
[9]
[35] array · 10 items
[0]
Location in lung parenchyma (central lung vs. peripheral lung)
[1]
−0.0709
[2]
0.932 (0.584–1.49)
[3]
−0.298
[4]
7.66E-01
[5]
[6]
[7]
[8]
[9]
[36] array · 10 items
[0]
KRAS mutation (yes vs. no)
[1]
−0.275
[2]
0.759 (0.316–1.82)
[3]
−0.616
[4]
5.38E-01
[5]
[6]
[7]
[8]
[9]
[37] array · 10 items
[0]
EGFR mutation (yes vs. no)
[1]
0.483
[2]
1.62 (1.06–2.49)
[3]
2.21
[4]
2.71E-02*
[5]
[6]
0.277
[7]
1.32 (0.812–2.14)
[8]
1.12
[9]
2.64E-01
[38] array · 10 items
[0]
EML4-ALK mutation (yes vs. no)
[1]
0.509
[2]
1.66 (0.965–2.87)
[3]
1.83
[4]
6.72E-02
[5]
[6]
[7]
[8]
[9]
[39] array · 10 items
[0]
Risk score
[1]
0.853
[2]
2.35 (1.74–3.16)
[3]
5.63
[4]
1.80E-08*
[5]
[6]
0.727
[7]
2.07 (1.22–3.52)
[8]
2.68
[9]
7.35E-03*
[40] array · 10 items
[0]
GSE72094 (overall survival)&
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[41] array · 10 items
[0]
Gender (male vs. female)
[1]
0.44
[2]
1.55 (1.07–2.25)
[3]
2.33
[4]
1.98E-02*
[5]
[6]
0.464
[7]
1.59 (1.09–2.33)
[8]
2.39
[9]
1.67E-02*
[42] array · 10 items
[0]
Age
[1]
0.00696
[2]
1.01 (0.988–1.03)
[3]
0.702
[4]
4.83E-01
[5]
[6]
[7]
[8]
[9]
[43] array · 10 items
[0]
Race (White vs. non-White)
[1]
−0.0694
[2]
0.933 (0.38–2.29)
[3]
−0.151
[4]
8.80E-01
[5]
[6]
[7]
[8]
[9]
[44] array · 10 items
[0]
Ethnicity (Hispanic or Latino vs. non-Hispanic or Latino)
[1]
−0.642
[2]
0.526 (0.0733–3.78)
[3]
−0.638
[4]
5.24E-01
[5]
[6]
[7]
[8]
[9]
[45] array · 10 items
[0]
Tobacco smoking history (ever vs. never)
[1]
0.314
[2]
1.37 (0.597–3.14)
[3]
0.741
[4]
4.59E-01
[5]
[6]
[7]
[8]
[9]
[46] array · 10 items
[0]
Tumor stage II (vs. stage I)
[1]
0.758
[2]
2.13 (1.32–3.44)
[3]
3.11
[4]
1.85E-03*
[5]
[6]
0.708
[7]
2.03 (1.25–3.28)
[8]
2.88
[9]
3.92E-03*
[47] array · 10 items
[0]
Tumor stage III (vs. stage I)
[1]
1.13
[2]
3.09 (1.93–4.97)
[3]
4.67
[4]
3.00E-06*
[5]
[6]
1.17
[7]
3.22 (1.99–5.22)
[8]
4.76
[9]
1.91E-06*
[48] array · 10 items
[0]
Tumor stage IV (vs. stage I)
[1]
1.21
[2]
3.35 (1.59–7.06)
[3]
3.18
[4]
1.48E-03*
[5]
[6]
1.14
[7]
3.13 (1.48–6.62)
[8]
2.99
[9]
2.80E-03*
[49] array · 10 items
[0]
KRAS mutation (yes vs. no)
[1]
0.376
[2]
1.46 (1–2.12)
[3]
1.97
[4]
4.92E-02*
[5]
[6]
0.157
[7]
1.17 (0.796–1.72)
[8]
0.799
[9]
4.24E-01
[50] array · 10 items
[0]
EGFR mutation (yes vs. no)
[1]
−1.34
[2]
0.262 (0.0965–0.71)
[3]
−2.63
[4]
8.49E-03*
[5]
[6]
−0.926
[7]
0.396 (0.143–1.1)
[8]
−1.78
[9]
7.52E-02
[51] array · 10 items
[0]
STK11 mutation (yes vs. no)
[1]
−0.0393
[2]
0.961 (0.58–1.59)
[3]
−0.153
[4]
8.79E-01
[5]
[6]
[7]
[8]
[9]
[52] array · 10 items
[0]
TP53 mutation (yes vs. no)
[1]
0.211
[2]
1.23 (0.82–1.86)
[3]
1.01
[4]
3.13E-01
[5]
[6]
[7]
[8]
[9]
[53] array · 10 items
[0]
Risk score
[1]
0.613
[2]
1.85 (1.47–2.31)
[3]
5.33
[4]
1.00E-07*
[5]
[6]
0.508
[7]
1.66 (1.31–2.11)
[8]
4.14
[9]
3.54E-05*
[54] array · 10 items
[0]
GSE68465 (overall survival)$
[1]
[2]
[3]
[4]
[5]
[6]
[7]
[8]
[9]
[55] array · 10 items
[0]
Gender (male vs. female)
[1]
0.33
[2]
1.39 (1.07–1.8)
[3]
2.5
[4]
1.25E-02*
[5]
[6]
0.324
[7]
1.38 (1.05–1.83)
[8]
2.27
[9]
2.32E-02*
[56] array · 10 items
[0]
Age
[1]
0.0266
[2]
1.03 (1.01–1.04)
[3]
3.97
[4]
7.16E-05*
[5]
[6]
0.0357
[7]
1.04 (1.02–1.05)
[8]
4.93
[9]
8.10E-07*
[57] array · 10 items
[0]
Race (White vs. non-White)
[1]
0.32
[2]
1.38 (0.702–2.71)
[3]
0.931
[4]
3.52E-01
[5]
[6]
[7]
[8]
[9]
[58] array · 10 items
[0]
Chemotherapy (yes vs. no)
[1]
0.488
[2]
1.63 (1.22–2.18)
[3]
3.29
[4]
9.99E-04*
[5]
[6]
0.243
[7]
1.28 (0.861–1.89)
[8]
1.21
[9]
2.25E-01
[59] array · 10 items
[0]
Radiation therapy (yes vs. no)
[1]
0.698
[2]
2.01 (1.47–2.75)
[3]
4.37
[4]
1.26E-05*
[5]
[6]
0.26
[7]
1.3 (0.838–2)
[8]
1.17
[9]
2.43E-01
[60] array · 10 items
[0]
T classification (T2 vs. T1)
[1]
0.381
[2]
1.46 (1.09–1.97)
[3]
2.52
[4]
1.18E-02*
[5]
[6]
0.126
[7]
1.13 (0.829–1.55)
[8]
0.786
[9]
4.32E-01
[61] array · 10 items
[0]
T classification (T3 vs. T1)
[1]
1.2
[2]
3.31 (2.06–5.34)
[3]
4.92
[4]
8.78E-07*
[5]
[6]
0.76
[7]
2.14 (1.29–3.55)
[8]
2.94
[9]
3.27E-03*
[62] array · 10 items
[0]
T classification (T4 vs. T1)
[1]
1.45
[2]
4.26 (2.17–8.34)
[3]
4.22
[4]
2.41E-05*
[5]
[6]
1.06
[7]
2.89 (1.36–6.13)
[8]
2.77
[9]
5.59E-03*
[63] array · 10 items
[0]
N classification (N1 vs. N0)
[1]
0.821
[2]
2.27 (1.67–3.09)
[3]
5.23
[4]
1.74E-07*
[5]
[6]
0.775
[7]
2.17 (1.57–3)
[8]
4.69
[9]
2.74E-06*
[64] array · 10 items
[0]
N classification (N2 vs. N0)
[1]
1.36
[2]
3.9 (2.77–5.48)
[3]
7.82
[4]
5.47E-15
[5]
[6]
1.24
[7]
3.45 (2.33–5.09)
[8]
6.22
[9]
5.08E-10*
[65] array · 10 items
[0]
Tobacco smoking history (ever vs. never)
[1]
0.22
[2]
1.25 (0.79–1.96)
[3]
0.946
[4]
3.44E-01
[5]
[6]
[7]
[8]
[9]
[66] array · 10 items
[0]
Risk score
[1]
0.331
[2]
1.39 (1.18–1.64)
[3]
3.94
[4]
8.17E-05*
[5]
[6]
0.356
[7]
1.43 (1.19–1.71)
[8]
3.84
[9]
1.22E-04*
locator
section[12]/table-wrap[1]#t4
gaps array · 4 items
[0]
asset:data:geo:GSE68465 not downloaded
[1]
asset:data:geo:GSE68465 licence not read
[2]
asset:data:geo:GSE72094 not downloaded
[3]
asset:data:geo:GSE72094 licence not read
analysis object · 4 fields
state
complete
methods array · 3 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Kaplan-Meier
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Cox regression
[2] object · 10 fields
id
method-3
family
diagnostic_evaluation
specific
roc
label
Diagnostic test evaluation
dsl_operations array · 6 items
[0]
confusion_counts
[1]
roc_curve
[2]
sensitivity_specificity
[3]
solve_confusion_matrix
[4]
classification_metrics
[5]
published_precision_envelope
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
reference_standard_and_test
evidence object · 3 fields
score
0.7
band
medium
quote
ROC analysis
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 2 items
[0]
GSE72094
[1]
GSE68465
resolved_accessions array · 2 items
[0]
GSE72094
[1]
GSE68465
statements array · 1 item
[0]
The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.
basis
The paper names GSE72094, GSE68465 in GEO database and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
survival_km
assets array · 6 items
[0]
source:pmid:34422970
[1]
data:geo:GSE68465
[2]
asset:table:pmid:34422970:1
[3]
asset:table:pmid:34422970:2
[4]
asset:table:pmid:34422970:3
[5]
asset:table:pmid:34422970:4
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE68465
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T19:46:13Z
independence
single_reader
evidence_check object · 2 fields
method
null
availability
null
calls
3
usage object · 3 fields
prompt_tokens
26836
completion_tokens
2616
cached_tokens
792
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:34422970
type
paper
label
pmid:34422970
[1] object · 3 fields
id
source:pmid:34422970
type
manuscript
label
PMID 34422970 full text
[2] object · 3 fields
id
data:geo:GSE68465
type
dataset
label
GEO GSE68465
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:34422970
type
paper
label
pmid:34422970
[1] object · 3 fields
id
source:pmid:34422970
type
manuscript
label
PMID 34422970 full text
[2] object · 3 fields
id
data:geo:GSE68465
type
dataset
label
GEO GSE68465
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-34422970
type
extraction
used array · 1 item
[0]
source:pmid:34422970
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE68465
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE68465
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:34422970
parent_hash
sha256:4e059392ef9dc8043caa45f12c48a7a3059ff9797ce93d5df4ad04dd35b2095d
fork_of
null
gaps array · 8 items
[0]
asset:data:geo:GSE68465 licence not read
[1]
asset:data:geo:GSE68465 not downloaded
[2]
asset:data:geo:GSE72094 licence not read
[3]
asset:data:geo:GSE72094 not downloaded
[4]
execution.not_run
[5]
review.human_critique
[6]
review.independent_reader
[7]
review.machine_critique
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
survival_km
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Kaplan-Meier
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:34422970", "kind": "science-record", "revision": 8, "content_hash": "sha256:86bbfc6b932970ecdb3eb4fae8853b2cf889649534991c0dc227f11e94e86337", "created_at": "2026-11-01T15:41:49Z", "updated_at": "2026-11-01T22:04:32Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Prognostic and immune implications of a novel ferroptosis-related ten-gene signature in lung adenocarcinoma.", "doi": "10.21037/atm-20-7936", "pmid": "34422970", "authors": ["Chao Ma", "Feng Li", "Huan Luo"], "journal": "Annals of translational medicine", "year": 2021, "abstract": "BACKGROUND: Lung cancer has been the focus of attention for many researchers in recent years due to its leading contribution to cancer-related death worldwide, with lung adenocarcinoma (LUAD) being the most common histological type. Ferroptosis, a novel iron-dependent form of regulated cell death, can be induced by sorafenib. Emerging evidence shows that triggering ferroptosis has potential as a cancer therapy. This work aimed to build a ferroptosis-related gene signature for predicting the outcome of LUAD.\nMETHODS: The TCGA-LUAD dataset was set as the training cohort, and the GSE72094 and GSE68465 datasets were set as the validation cohorts. Sixty-two ferroptosis-related genes were retrieved from the literature. A univariate Cox regression model was constructed for the training cohort to preliminarily screen for potential prognostic ferroptosis-related genes. A gene signature was generated from a LASSO Cox regression model and assessed with the training and validation cohorts through Kaplan-Meier, Cox, and ROC analyses. In addition, the correlation between the risk score and autophagy-related genes was determined by the Pearson test. Finally, GSEA and immune infiltrating analyses were performed to better study the functional annotation of the signature and the role of each kind of immune cell.\nRESULTS: A ten-gene signature was constructed from the training cohort and validated in three cohorts by Kaplan-Meier and Cox regression analyses, revealing its independent prognostic value in LUAD. Moreover, a ROC analysis conducted with all cohort data confirmed the predictive ability of the ten-gene signature for LUAD prognosis. A total of 62.85% (308/490) of autophagy-related genes were found to be significantly correlated with risk scores. GSEA detailed the exact pathways related to the gene signature, and immune-infiltrating analyses identified crucial roles for resting mast cells and resting dendritic cells in the prognosis of LUAD.\nCONCLUSIONS: We identified a novel ferroptosis-related ten-gene signature (PHKG2, PGD, PEBP1, NCOA4, GLS2, CISD1, ATP5G3, ALOX15, ALOX12B, and ACSL3) that can accurately predict LUAD prognosis and is closely linked to resting mast cells and resting dendritic cells.", "claims": [{"id": "claim-data-access", "statement": "The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:34422970", "locator": "sections[3] \"Cohorts and ferroptosis-related genes\" paragraph 2", "quote": "The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:34422970"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE68465"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE68465"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:34422970", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.21037/atm-20-7936", "sha256": "sha256:e7a68e5752a4517e78a6fce76ead1e5a37d230abd307fe575bf288c108d6382f", "bytes": 38851, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.21037/atm-20-7936", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC8339871", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE68465", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE68465", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE68465", "version": null, "note": "The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM1672281", "GSM1672282", "GSM1672283", "GSM1672284", "GSM1672285", "GSM1672286", "GSM1672287", "GSM1672288", "GSM1672289", "GSM1672290", "GSM1672291", "GSM1672292", "GSM1672293", "GSM1672294", "GSM1672295", "GSM1672296", "GSM1672297", "GSM1672298", "GSM1672299", "GSM1672300", "GSM1672301", "GSM1672302", "GSM1672303", "GSM1672304", "GSM1672305", "GSM1672306", "GSM1672307", "GSM1672308", "GSM1672309", "GSM1672310", "GSM1672311", "GSM1672312", "GSM1672313", "GSM1672314", "GSM1672315", "GSM1672316", "GSM1672317", "GSM1672318", "GSM1672319", "GSM1672320", "GSM1672321", "GSM1672322", "GSM1672323", "GSM1672324", "GSM1672325", "GSM1672326", "GSM1672327", "GSM1672328", "GSM1672329", "GSM1672330", "GSM1672331", "GSM1672332", "GSM1672333", "GSM1672334", "GSM1672335", "GSM1672336", "GSM1672337", "GSM1672338", "GSM1672339", "GSM1672340", "GSM1672341", "GSM1672342", "GSM1672343", "GSM1672344", "GSM1672345", "GSM1672346", "GSM1672347", "GSM1672348", "GSM1672349", "GSM1672350", "GSM1672351", "GSM1672352", "GSM1672353", "GSM1672354", "GSM1672355", "GSM1672356", "GSM1672357", "GSM1672358", "GSM1672359", "GSM1672360", "GSM1672361", "GSM1672362", "GSM1672363", "GSM1672364", "GSM1672365", "GSM1672366", "GSM1672367", "GSM1672368", "GSM1672369", "GSM1672370", "GSM1672371", "GSM1672372", "GSM1672373", "GSM1672374", "GSM1672375", "GSM1672376", "GSM1672377", "GSM1672378", "GSM1672379", "GSM1672380", "GSM1672381", "GSM1672382", "GSM1672383", "GSM1672384", "GSM1672385", "GSM1672386", "GSM1672387", "GSM1672388", "GSM1672389", "GSM1672390", "GSM1672391", "GSM1672392", "GSM1672393", "GSM1672394", "GSM1672395", "GSM1672396", "GSM1672397", "GSM1672398", "GSM1672399", "GSM1672400", "GSM1672401", "GSM1672402", "GSM1672403", "GSM1672404", "GSM1672405", "GSM1672406", "GSM1672407", "GSM1672408", "GSM1672409", "GSM1672410", "GSM1672411", "GSM1672412", "GSM1672413", "GSM1672414", "GSM1672415", "GSM1672416", "GSM1672417", "GSM1672418", "GSM1672419", "GSM1672420", "GSM1672421", "GSM1672422", "GSM1672423", "GSM1672424", "GSM1672425", "GSM1672426", "GSM1672427", "GSM1672428", "GSM1672429", "GSM1672430", "GSM1672431", "GSM1672432", "GSM1672433", "GSM1672434", "GSM1672435", "GSM1672436", "GSM1672437", "GSM1672438", "GSM1672439", "GSM1672440", "GSM1672441", "GSM1672442", "GSM1672443", "GSM1672444", "GSM1672445", "GSM1672446", "GSM1672447", "GSM1672448", "GSM1672449", "GSM1672450", "GSM1672451", "GSM1672452", "GSM1672453", "GSM1672454", "GSM1672455", "GSM1672456", "GSM1672457", "GSM1672458", "GSM1672459", "GSM1672460", "GSM1672461", "GSM1672462", "GSM1672463", "GSM1672464", "GSM1672465", "GSM1672466", "GSM1672467", "GSM1672468", "GSM1672469", "GSM1672470", "GSM1672471", "GSM1672472", "GSM1672473", "GSM1672474", "GSM1672475", "GSM1672476", "GSM1672477", "GSM1672478", "GSM1672479", "GSM1672480", "GSM1672481", "GSM1672482", "GSM1672483", "GSM1672484", "GSM1672485", "GSM1672486", "GSM1672487", "GSM1672488", "GSM1672489", "GSM1672490", "GSM1672491", "GSM1672492", "GSM1672493", "GSM1672494", "GSM1672495", "GSM1672496", "GSM1672497", "GSM1672498", "GSM1672499", "GSM1672500", "GSM1672501", "GSM1672502", "GSM1672503", "GSM1672504", "GSM1672505", "GSM1672506", "GSM1672507", "GSM1672508", "GSM1672509", "GSM1672510", "GSM1672511", "GSM1672512", "GSM1672513", "GSM1672514", "GSM1672515", "GSM1672516", "GSM1672517", "GSM1672518", "GSM1672519", "GSM1672520", "GSM1672521", "GSM1672522", "GSM1672523", "GSM1672524", "GSM1672525", "GSM1672526", "GSM1672527", "GSM1672528", "GSM1672529", "GSM1672530", "GSM1672531", "GSM1672532", "GSM1672533", "GSM1672534", "GSM1672535", "GSM1672536", "GSM1672537", "GSM1672538", "GSM1672539", "GSM1672540", "GSM1672541", "GSM1672542", "GSM1672543", "GSM1672544", "GSM1672545", "GSM1672546", "GSM1672547", "GSM1672548", "GSM1672549", "GSM1672550", "GSM1672551", "GSM1672552", "GSM1672553", "GSM1672554", "GSM1672555", "GSM1672556", "GSM1672557", "GSM1672558", "GSM1672559", "GSM1672560", "GSM1672561", "GSM1672562", "GSM1672563", "GSM1672564", "GSM1672565", "GSM1672566", "GSM1672567", "GSM1672568", "GSM1672569", "GSM1672570", "GSM1672571", "GSM1672572", "GSM1672573", "GSM1672574", "GSM1672575", "GSM1672576", "GSM1672577", "GSM1672578", "GSM1672579", "GSM1672580", "GSM1672581", "GSM1672582", "GSM1672583", "GSM1672584", "GSM1672585", "GSM1672586", "GSM1672587", "GSM1672588", "GSM1672589", "GSM1672590", "GSM1672591", "GSM1672592", "GSM1672593", "GSM1672594", "GSM1672595", "GSM1672596", "GSM1672597", "GSM1672598", "GSM1672599", "GSM1672600", "GSM1672601", "GSM1672602", "GSM1672603", "GSM1672604", "GSM1672605", "GSM1672606", "GSM1672607", "GSM1672608", "GSM1672609", "GSM1672610", "GSM1672611", "GSM1672612", "GSM1672613", "GSM1672614", "GSM1672615", "GSM1672616", "GSM1672617", "GSM1672618", "GSM1672619", "GSM1672620", "GSM1672621", "GSM1672622", "GSM1672623", "GSM1672624", "GSM1672625", "GSM1672626", "GSM1672627", "GSM1672628", "GSM1672629", "GSM1672630", "GSM1672631", "GSM1672632", "GSM1672633", "GSM1672634", "GSM1672635", "GSM1672636", "GSM1672637", "GSM1672638", "GSM1672639", "GSM1672640", "GSM1672641", "GSM1672642", "GSM1672643", "GSM1672644", "GSM1672645", "GSM1672646", "GSM1672647", "GSM1672648", "GSM1672649", "GSM1672650", "GSM1672651", "GSM1672652", "GSM1672653", "GSM1672654", "GSM1672655", "GSM1672656", "GSM1672657", "GSM1672658", "GSM1672659", "GSM1672660", "GSM1672661", "GSM1672662", "GSM1672663", "GSM1672664", "GSM1672665", "GSM1672666", "GSM1672667", "GSM1672668", "GSM1672669", "GSM1672670", "GSM1672671", "GSM1672672", "GSM1672673", "GSM1672674", "GSM1672675", "GSM1672676", "GSM1672677", "GSM1672678", "GSM1672679", "GSM1672680", "GSM1672681", "GSM1672682", "GSM1672683", "GSM1672684", "GSM1672685", "GSM1672686", "GSM1672687", "GSM1672688", "GSM1672689", "GSM1672690", "GSM1672691", "GSM1672692", "GSM1672693", "GSM1672694", "GSM1672695", "GSM1672696", "GSM1672697", "GSM1672698", "GSM1672699", "GSM1672700", "GSM1672701", "GSM1672702", "GSM1672703", "GSM1672704", "GSM1672705", "GSM1672706", "GSM1672707", "GSM1672708", "GSM1672709", "GSM1672710", "GSM1672711", "GSM1672712", "GSM1672713", "GSM1672714", "GSM1672715", "GSM1672716", "GSM1672717", "GSM1672718", "GSM1672719", "GSM1672720", "GSM1672721", "GSM1672722", "GSM1672723", "GSM1672724", "GSM1672725", "GSM1672726", "GSM1672727", "GSM1672728", "GSM1672729", "GSM1672730", "GSM1672731", "GSM1672732", "GSM1672733", "GSM1672734", "GSM1672735", "GSM1672736", "GSM1672737", "GSM1672738", "GSM1672739", "GSM1672740", "GSM1672741", "GSM1672742"], "sample_count": 462, "group_sizes": null, "group_sizes_basis": null, "platform": "96", "taxon": "Homo sapiens", "title": "caArray_jacob-00182: Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE72094", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE72094", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE72094", "version": null, "note": "The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research.", "access_statement_kind": "repository_route_statement", "sample_accessions": ["GSM1854797", "GSM1854798", "GSM1854799", "GSM1854800", "GSM1854801", "GSM1854802", "GSM1854803", "GSM1854804", "GSM1854805", "GSM1854806", "GSM1854807", "GSM1854808", "GSM1854809", "GSM1854810", "GSM1854811", "GSM1854812", "GSM1854813", "GSM1854814", "GSM1854815", "GSM1854816", "GSM1854817", "GSM1854818", "GSM1854819", "GSM1854820", "GSM1854821", "GSM1854822", "GSM1854823", "GSM1854824", "GSM1854825", "GSM1854826", "GSM1854827", "GSM1854828", "GSM1854829", "GSM1854830", "GSM1854831", "GSM1854832", "GSM1854833", "GSM1854834", "GSM1854835", "GSM1854836", "GSM1854837", "GSM1854838", "GSM1854839", "GSM1854840", "GSM1854841", "GSM1854842", "GSM1854843", "GSM1854844", "GSM1854845", "GSM1854846", "GSM1854847", "GSM1854848", "GSM1854849", "GSM1854850", "GSM1854851", "GSM1854852", "GSM1854853", "GSM1854854", "GSM1854855", "GSM1854856", "GSM1854857", "GSM1854858", "GSM1854859", "GSM1854860", "GSM1854861", "GSM1854862", "GSM1854863", "GSM1854864", "GSM1854865", "GSM1854866", "GSM1854867", "GSM1854868", "GSM1854869", "GSM1854870", "GSM1854871", "GSM1854872", "GSM1854873", "GSM1854874", "GSM1854875", "GSM1854876", "GSM1854877", "GSM1854878", "GSM1854879", "GSM1854880", "GSM1854881", "GSM1854882", "GSM1854883", "GSM1854884", "GSM1854885", "GSM1854886", "GSM1854887", "GSM1854888", "GSM1854889", "GSM1854890", "GSM1854891", "GSM1854892", "GSM1854893", "GSM1854894", "GSM1854895", "GSM1854896", "GSM1854897", "GSM1854898", "GSM1854899", "GSM1854900", "GSM1854901", "GSM1854902", "GSM1854903", "GSM1854904", "GSM1854905", "GSM1854906", "GSM1854907", "GSM1854908", "GSM1854909", "GSM1854910", "GSM1854911", "GSM1854912", "GSM1854913", "GSM1854914", "GSM1854915", "GSM1854916", "GSM1854917", "GSM1854918", "GSM1854919", "GSM1854920", "GSM1854921", "GSM1854922", "GSM1854923", "GSM1854924", "GSM1854925", "GSM1854926", "GSM1854927", "GSM1854928", "GSM1854929", "GSM1854930", "GSM1854931", "GSM1854932", "GSM1854933", "GSM1854934", "GSM1854935", "GSM1854936", "GSM1854937", "GSM1854938", "GSM1854939", "GSM1854940", "GSM1854941", "GSM1854942", "GSM1854943", "GSM1854944", "GSM1854945", "GSM1854946", "GSM1854947", "GSM1854948", "GSM1854949", "GSM1854950", "GSM1854951", "GSM1854952", "GSM1854953", "GSM1854954", "GSM1854955", "GSM1854956", "GSM1854957", "GSM1854958", "GSM1854959", "GSM1854960", "GSM1854961", "GSM1854962", "GSM1854963", "GSM1854964", "GSM1854965", "GSM1854966", "GSM1854967", "GSM1854968", "GSM1854969", "GSM1854970", "GSM1854971", "GSM1854972", "GSM1854973", "GSM1854974", "GSM1854975", "GSM1854976", "GSM1854977", "GSM1854978", "GSM1854979", "GSM1854980", "GSM1854981", "GSM1854982", "GSM1854983", "GSM1854984", "GSM1854985", "GSM1854986", "GSM1854987", "GSM1854988", "GSM1854989", "GSM1854990", "GSM1854991", "GSM1854992", "GSM1854993", "GSM1854994", "GSM1854995", "GSM1854996", "GSM1854997", "GSM1854998", "GSM1854999", "GSM1855000", "GSM1855001", "GSM1855002", "GSM1855003", "GSM1855004", "GSM1855005", "GSM1855006", "GSM1855007", "GSM1855008", "GSM1855009", "GSM1855010", "GSM1855011", "GSM1855012", "GSM1855013", "GSM1855014", "GSM1855015", "GSM1855016", "GSM1855017", "GSM1855018", "GSM1855019", "GSM1855020", "GSM1855021", "GSM1855022", "GSM1855023", "GSM1855024", "GSM1855025", "GSM1855026", "GSM1855027", "GSM1855028", "GSM1855029", "GSM1855030", "GSM1855031", "GSM1855032", "GSM1855033", "GSM1855034", "GSM1855035", "GSM1855036", "GSM1855037", "GSM1855038", "GSM1855039", "GSM1855040", "GSM1855041", "GSM1855042", "GSM1855043", "GSM1855044", "GSM1855045", "GSM1855046", "GSM1855047", "GSM1855048", "GSM1855049", "GSM1855050", "GSM1855051", "GSM1855052", "GSM1855053", "GSM1855054", "GSM1855055", "GSM1855056", "GSM1855057", "GSM1855058", "GSM1855059", "GSM1855060", "GSM1855061", "GSM1855062", "GSM1855063", "GSM1855064", "GSM1855065", "GSM1855066", "GSM1855067", "GSM1855068", "GSM1855069", "GSM1855070", "GSM1855071", "GSM1855072", "GSM1855073", "GSM1855074", "GSM1855075", "GSM1855076", "GSM1855077", "GSM1855078", "GSM1855079", "GSM1855080", "GSM1855081", "GSM1855082", "GSM1855083", "GSM1855084", "GSM1855085", "GSM1855086", "GSM1855087", "GSM1855088", "GSM1855089", "GSM1855090", "GSM1855091", "GSM1855092", "GSM1855093", "GSM1855094", "GSM1855095", "GSM1855096", "GSM1855097", "GSM1855098", "GSM1855099", "GSM1855100", "GSM1855101", "GSM1855102", "GSM1855103", "GSM1855104", "GSM1855105", "GSM1855106", "GSM1855107", "GSM1855108", "GSM1855109", "GSM1855110", "GSM1855111", "GSM1855112", "GSM1855113", "GSM1855114", "GSM1855115", "GSM1855116", "GSM1855117", "GSM1855118", "GSM1855119", "GSM1855120", "GSM1855121", "GSM1855122", "GSM1855123", "GSM1855124", "GSM1855125", "GSM1855126", "GSM1855127", "GSM1855128", "GSM1855129", "GSM1855130", "GSM1855131", "GSM1855132", "GSM1855133", "GSM1855134", "GSM1855135", "GSM1855136", "GSM1855137", "GSM1855138", "GSM1855139", "GSM1855140", "GSM1855141", "GSM1855142", "GSM1855143", "GSM1855144", "GSM1855145", "GSM1855146", "GSM1855147", "GSM1855148", "GSM1855149", "GSM1855150", "GSM1855151", "GSM1855152", "GSM1855153", "GSM1855154", "GSM1855155", "GSM1855156", "GSM1855157", "GSM1855158", "GSM1855159", "GSM1855160", "GSM1855161", "GSM1855162", "GSM1855163", "GSM1855164", "GSM1855165", "GSM1855166", "GSM1855167", "GSM1855168", "GSM1855169", "GSM1855170", "GSM1855171", "GSM1855172", "GSM1855173", "GSM1855174", "GSM1855175", "GSM1855176", "GSM1855177", "GSM1855178", "GSM1855179", "GSM1855180", "GSM1855181", "GSM1855182", "GSM1855183", "GSM1855184", "GSM1855185", "GSM1855186", "GSM1855187", "GSM1855188", "GSM1855189", "GSM1855190", "GSM1855191", "GSM1855192", "GSM1855193", "GSM1855194", "GSM1855195", "GSM1855196", "GSM1855197", "GSM1855198", "GSM1855199", "GSM1855200", "GSM1855201", "GSM1855202", "GSM1855203", "GSM1855204", "GSM1855205", "GSM1855206", "GSM1855207", "GSM1855208", "GSM1855209", "GSM1855210", "GSM1855211", "GSM1855212", "GSM1855213", "GSM1855214", "GSM1855215", "GSM1855216", "GSM1855217", "GSM1855218", "GSM1855219", "GSM1855220", "GSM1855221", "GSM1855222", "GSM1855223", "GSM1855224", "GSM1855225", "GSM1855226", "GSM1855227", "GSM1855228", "GSM1855229", "GSM1855230", "GSM1855231", "GSM1855232", "GSM1855233", "GSM1855234", "GSM1855235", "GSM1855236", "GSM1855237", "GSM1855238"], "sample_count": 442, "group_sizes": null, "group_sizes_basis": null, "platform": "15048", "taxon": "Homo sapiens", "title": "KRAS mutation-associated gene expression, p53 and STK11 mutations, proliferation and immune surveillance in lung adenocarcinoma", "resolution_checked_at": "2026-11-01T15:39:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:34422970:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:a8f449ef2de4d59b5d29ccdcf8c3ba1fb5845e9d1e6247113cc0f6a59bf20ac3", "bytes": 4027, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[10]/table-wrap[1]#t1", "version": null, "note": "Clinical characteristics of patients involved in the study", "structure": {"pmcid": "PMC8339871", "section_index": 10, "section_title": "Cohorts’ characteristics", "row_count": 98, "column_count": 4}, "table": {"label": "Table 1", "caption": "Clinical characteristics of patients involved in the study", "rows": [["Characteristics", "Training cohort (TCGA-LUAD, 500 cases)", "Validation cohort (GSE72094, 442 cases)", "Validation cohort (GSE68465, 443 cases)"], ["Age", "", "", ""], ["<65", "219 (43.8%)", "115 (26.02%)", "214 (48.31%)"], ["≥65", "271 (54.2%)", "306 (69.23%)", "229 (51.69%)"], ["Unknown", "10 (2%)", "21 (4.75%)", "0"], ["Gender", "", "", ""], ["Female", "270 (54%)", "240 (54.3%)", "220 (49.66%)"], ["Male", "230 (46%)", "202 (45.7%)", "223 (50.34%)"], ["T classification", "", "", ""], ["T1", "167 (33.4%)", "NA", "150 (33.86%)"], ["T2", "267 (53.4%)", "NA", "251 (56.66%)"], ["T3", "45 (9%)", "NA", "28 (6.32%)"], ["T4", "18 (3.6%)", "NA", "12 (2.71%)"], ["Unknown", "3 (0.6%)", "NA", "2 (0.45%)"], ["N classification", "", "", ""], ["N0", "324 (64.8%)", "NA", "299 (67.49%)"], ["N1", "94 (18.8%)", "NA", "88 (19.86%)"], ["N2", "69 (13.8%)", "NA", "53 (11.96%)"], ["N3", "2 (0.4%)", "NA", "0"], ["Unknown", "11 (2.2%)", "NA", "3 (0.68%)"], ["M classification", "", "", ""], ["M0", "332 (66.4%)", "NA", "NA"], ["M1", "24 (4.8%)", "NA", "NA"], ["Unknown", "144 (28.8%)", "NA", "NA"], ["Tumor stage", "", "", ""], ["Stage I", "268 (53.6%)", "265 (59.95%)", "NA"], ["Stage II", "119 (23.8%)", "69 (15.61%)", "NA"], ["Stage III", "80 (16%)", "63 (14.25%)", "NA"], ["Stage IV", "25 (5%)", "17 (3.85%)", "NA"], ["Unknown", "8 (1.6%)", "28 (6.33%)", "NA"], ["Race", "", "", ""], ["White", "386 (77.2%)", "399 (90.27%)", "295 (66.59%)"], ["Black or African American", "52 (10.4%)", "13 (2.94%)", "12 (2.71%)"], ["American Indian or Alaska Native", "1 (0.2%)", "0", "1 (0.23%)"], ["Asian", "7 (1.4%)", "3 (0.68%)", "6 (1.35%)"], ["Unknown", "54 (10.8%)", "27 (6.11%)", "129 (29.12%)"], ["Ethnicity", "", "", ""], ["Hispanic or Latino", "7 (1.4%)", "10 (2.26%)", "NA"], ["Not Hispanic or Latino", "381 (76.2%)", "402 (90.95%)", "NA"], ["Unknown", "112 (22.4%)", "30 (6.79%)", "NA"], ["Tobacco smoking history", "", "", ""], ["Ever", "415 (83%)", "335 (75.79%)", "300 (67.72%)"], ["Never", "71 (14.2%)", "33 (7.47%)", "49 (11.06%)"], ["Unknown", "14 (2.8%)", "74 (16.74%)", "94 (21.22%)"], ["Number pack-years smoked", "", "", ""], ["<30", "115 (23%)", "NA", "NA"], ["≥30", "227 (45.4%)", "NA", "NA"], ["Unknown", "158 (31.6%)", "NA", "NA"], ["Radiation therapy", "", "", ""], ["Yes", "58 (11.6%)", "NA", "65 (14.67%)"], ["No", "361 (72.2%)", "NA", "364 (82.17%)"], ["Unknown", "81 (16.2%)", "NA", "14 (3.16%)"], ["Chemotherapy", "", "", ""], ["Yes", "NA", "NA", "89 (20.09%)"], ["No", "NA", "NA", "341 (76.98%)"], ["Unknown", "NA", "NA", "13 (2.93%)"], ["Additional pharmaceutical therapy", "", ""], ["Yes", "61 (12.2%)", "NA", "NA"], ["No", "68 (13.6%)", "NA", "NA"], ["Unknown", "371 (74.2%)", "NA", "NA"], ["Additional radiation therapy", "", "", ""], ["Yes", "61 (12.2%)", "NA", "NA"], ["No", "71 (14.2%)", "NA", "NA"], ["Unknown", "368 (73.6%)", "NA", "NA"], ["EGFR mutation", "", "", ""], ["Yes", "80 (16%)", "47 (10.63%)", "NA"], ["No", "191 (38.2%)", "395 (89.37%)", "NA"], ["Unknown", "229 (45.8%)", "0", "NA"], ["KRAS mutation", "", "", ""], ["Yes", "23 (4.6%)", "154 (34.84%)", "NA"], ["No", "39 (7.8%)", "288 (65.16%)", "NA"], ["Unknown", "438 (87.6%)", "0", "NA"], ["STK11 mutation", "", "", ""], ["Yes", "NA", "68 (15.38%)", "NA"], ["No", "NA", "374 (84.62%)", "NA"], ["TP53 mutation", "", "", ""], ["Yes", "NA", "111 (25.11%)", "NA"], ["No", "NA", "331 (74.89%)", "NA"], ["EML4-ALK mutation", "", "", ""], ["Yes", "34 (6.8%)", "NA", "NA"], ["No", "207 (41.4%)", "NA", "NA"], ["Unknown", "259 (51.8%)", "NA", "NA"], ["Tumor intermediate dimension", "", ""], ["<1", "287 (57.4%)", "NA", "NA"], ["≥1", "88 (17.6%)", "NA", "NA"], ["Unknown", "125 (25%)", "NA", "NA"], ["Location in lung parenchyma", "", "", ""], ["Central lung", "62 (12.4%)", "NA", "NA"], ["Peripheral lung", "118 (23.6%)", "NA", "NA"], ["Unknown", "320 (64%)", "NA", "NA"], ["Person neoplasm cancer status", "", ""], ["With tumor", "134 (26.8%)", "NA", "NA"], ["Tumor free", "243 (48.6%)", "NA", "NA"], ["Unknown", "123 (24.6%)", "NA", "NA"], ["Vital status", "", "", ""], ["Alive", "318 (63.6%)", "298 (67.42%)", "207 (46.73%)"], ["Dead", "182 (36.4%)", "122 (27.6%)", "236 (53.27%)"], ["Unknown", "0", "22 (4.98%)", "NA"]], "row_count": 98, "column_count": 4, "numeric_cells": 143, "header_rows": 1, "locator": "section[10]/table-wrap[1]#t1"}}, {"id": "asset:table:pmid:34422970:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:af60f9de62ac4bb361a71c47a9ed9536397621443f7d9a8296ad931a5388110f", "bytes": 1757, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#t2", "version": null, "note": "14 ferroptosis-related potential prognostic genes generated from the training cohort", "structure": {"pmcid": "PMC8339871", "section_index": 11, "section_title": "Identification of a prognostic ferroptosis-related gene signature from the training cohort", "row_count": 16, "column_count": 6}, "table": {"label": "Table 2", "caption": "14 ferroptosis-related potential prognostic genes generated from the training cohort", "rows": [["Gene symbol", "Description", "HR", "95% confidence interval", "P value"], ["Lower", "Upper"], ["PEBP1", "Phosphatidylethanolamine-Binding Protein 1", "0.603658936", "0.464865289", "0.78389185", "0.000152746"], ["ACSL3", "Acyl-CoA Synthetase Long-Chain Family Member 3", "1.435108616", "1.157210163", "1.779743045", "0.001003251"], ["GLS2", "Glutaminase 2", "0.356469987", "0.176890046", "0.71836067", "0.003911814"], ["GCLC", "Glutamate-Cysteine Ligase Catalytic Subunit", "1.135847381", "1.034367787", "1.24728292", "0.007639188"], ["SLC7A11", "Solute Carrier Family 7 Member 11", "1.137868621", "1.023951703", "1.264459052", "0.016406631"], ["PHKG2", "Phosphorylase Kinase Catalytic Subunit Gamma 2", "0.69374619", "0.511654438", "0.940642238", "0.018577862"], ["PGD", "Phosphogluconate Dehydrogenase", "1.177966423", "1.02132216", "1.358635842", "0.02446422"], ["CISD1", "CDGSH Iron Sulfur Domain 1", "1.403301444", "1.041497232", "1.890792296", "0.025931782"], ["ALOX12B", "Arachidonate 12-Lipoxygenase, 12R Type", "1.528527805", "1.03748207", "2.251988076", "0.031866869"], ["DPP4", "Dipeptidyl Peptidase 4", "0.911077238", "0.836744384", "0.992013511", "0.031983077"], ["ALOX15", "Arachidonate 15-Lipoxygenase", "0.857033797", "0.740142144", "0.992386306", "0.039196308"], ["ATP5G3", "ATP Synthase Membrane Subunit C Locus 3", "1.311553769", "1.01163069", "1.700396506", "0.040633369"], ["ABCC1", "ATP Binding Cassette Subfamily C Member 1", "1.23437377", "1.007318781", "1.512608156", "0.042328557"], ["NCOA4", "Nuclear Receptor Coactivator 4", "0.776056577", "0.603024235", "0.998738982", "0.048865024"]], "row_count": 16, "column_count": 6, "numeric_cells": 72, "header_rows": 2, "locator": "section[11]/table-wrap[1]#t2"}}, {"id": "asset:table:pmid:34422970:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:e371ce4db74b4bb3c542daa5d9d067e9016cd44760ffb44ffd99c1d8d8179dd1", "bytes": 902, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[2]#t3", "version": null, "note": "10 ferroptosis-related prognostic genes obtained from LASSO Cox regression model", "structure": {"pmcid": "PMC8339871", "section_index": 11, "section_title": "Identification of a prognostic ferroptosis-related gene signature from the training cohort", "row_count": 11, "column_count": 3}, "table": {"label": "Table 3", "caption": "10 ferroptosis-related prognostic genes obtained from LASSO Cox regression model", "rows": [["Gene symbol", "Description", "Risk coefficient"], ["PHKG2", "Phosphorylase Kinase Catalytic Subunit Gamma 2", "−0.376487238"], ["PGD", "Phosphogluconate Dehydrogenase", "0.027750809"], ["PEBP1", "Phosphatidylethanolamine Binding Protein 1", "−0.369553219"], ["NCOA4", "Nuclear Receptor Coactivator 4", "−0.498545244"], ["GLS2", "Glutaminase 2", "−0.399525822"], ["CISD1", "CDGSH Iron Sulfur Domain 1", "0.313326653"], ["ATP5G3", "ATP Synthase Membrane Subunit C Locus 3", "0.019018653"], ["ALOX15", "Arachidonate 15-Lipoxygenase", "−0.049973524"], ["ALOX12B", "Arachidonate 12-Lipoxygenase, 12R Type", "0.323899465"], ["ACSL3", "Acyl-CoA Synthetase Long Chain Family Member 3", "0.246495026"]], "row_count": 11, "column_count": 3, "numeric_cells": 21, "header_rows": 1, "locator": "section[11]/table-wrap[2]#t3"}}, {"id": "asset:table:pmid:34422970:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:f958976cfdaae725dac9f3b89b533f2f1ab7b0b3a4a3044246dc661fcd3105ff", "bytes": 7789, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#t4", "version": null, "note": "Univariate analysis and multivariate analysis of the correlation of gene signature risk score with outcomes among lung adenocarcinoma patients in three cohorts", "structure": {"pmcid": "PMC8339871", "section_index": 12, "section_title": "Prognostic ability of the ten-gene signature", "row_count": 67, "column_count": 10}, "table": {"label": "Table 4", "caption": "Univariate analysis and multivariate analysis of the correlation of gene signature risk score with outcomes among lung adenocarcinoma patients in three cohorts", "rows": [["Variable", "Univariate Cox analysis", "", "Multivariate Cox analysis"], ["coef", "HR (95% CI)", "z", "P value", "coef", "HR (95% CI)", "z", "P value"], ["TCGA-LUAD (overall survival)^", "", "", "", "", "", "", "", "", ""], ["Gender (male vs. female)", "0.048", "1.05 (0.784–1.4)", "0.322", "7.47E-01", "", "", "", "", ""], ["Age", "0.00816", "1.01 (0.993–1.02)", "1.05", "2.94E-01", "", "", "", "", ""], ["Tumor stage II (vs. stage I)", "0.905", "2.47 (1.72–3.56)", "4.87", "1.09E-06*", "", "1.32", "3.75 (1.44–9.8)", "2.7", "6.93E-03"], ["Tumor stage III (vs. stage I)", "1.25", "3.49 (2.38–5.12)", "6.4", "1.51E-10*", "", "0.455", "1.58 (0.445–5.59)", "0.705", "4.81E-01"], ["Tumor stage IV (vs. stage I)", "1.34", "3.82 (2.2–6.62)", "4.76", "1.92E-06*", "", "−0.107", "0.899 (0.255–3.17)", "−0.166", "8.68E-01"], ["Tobacco smoking history (ever vs. never)", "−0.127", "0.88 (0.583–1.33)", "−0.605", "5.45E-01", "", "", "", "", ""], ["Number pack years smoked", "0.00327", "1 (0.996–1.01)", "0.938", "3.48E-01", "", "", "", "", ""], ["Race (White vs. non-White)", "0.36", "1.43 (0.875–2.34)", "1.43", "1.53E-01", "", "", "", "", ""], ["Ethnicity (Hispanic or Latino vs. Non-Hispanic or Latino)", "0.387", "1.47 (0.466–4.65)", "0.658", "5.10E-01", "", "", "", "", ""], ["Tumor intermediate dimension", "0.441", "1.55 (0.922–2.62)", "1.65", "9.80E-02", "", "", "", "", ""], ["Radiation therapy (yes vs. no)", "0.763", "2.14 (1.44–3.19)", "3.76", "1.73E-04*", "", "0.446", "1.56 (0.415–5.88)", "0.66", "5.09E-01"], ["Additional pharmaceutical therapy (yes vs. no)", "−0.502", "0.605 (0.382–0.959)", "−2.14", "3.26E-02*", "", "−1.03", "0.356 (0.158–0.8)", "−2.5", "1.25E-02*"], ["Additional radiation therapy (yes vs. no)", "−0.0153", "0.985 (0.625–1.55)", "−0.0661", "9.47E-01", "", "", "", "", ""], ["Location in lung parenchyma (central lung vs. peripheral lung)", "0.0908", "1.09 (0.684–1.75)", "0.378", "7.06E-01", "", "", "", "", ""], ["KRAS mutation (yes vs. no)", "0.492", "1.63 (0.672–3.98)", "1.08", "2.78E-01", "", "", "", "", ""], ["EGFR mutation (yes vs. no)", "0.268", "1.31 (0.828–2.06)", "1.15", "2.50E-01", "", "", "", "", ""], ["EML4-ALK mutation (yes vs. no)", "0.592", "1.81 (1.01–3.24)", "1.98", "4.73E-02*", "", "1.18", "3.25 (1.22–8.63)", "2.36", "1.84E-02*"], ["Risk score", "1.22", "3.39 (2.49–4.62)", "7.76", "8.78E-15*", "", "1.99", "7.32 (2.88–18.6)", "4.18", "2.94E-05*"], ["TCGA-LUAD (progression-free survival)#", "", "", "", "", "", "", "", "", ""], ["Gender (male vs. female)", "0.07", "1.07 (0.815–1.41)", "0.499", "6.17E-01", "", "", "", "", ""], ["Age", "−0.000998", "0.999 (0.985–1.01)", "−0.141", "8.88E-01", "", "", "", "", ""], ["Tumor stage II (vs. stage I)", "0.798", "2.22 (1.61–3.07)", "4.85", "1.22E-06*", "", "1.2", "3.33 (1.92–5.78)", "4.28", "1.88E-05*"], ["Tumor stage III (vs. stage I)", "0.709", "2.03 (1.38–2.99)", "3.61", "3.10E-04*", "", "0.95", "2.59 (1.31–5.11)", "2.73", "6.25E-03*"], ["Tumor stage IV (vs. stage I)", "0.849", "2.34 (1.32–4.13)", "2.93", "3.40E-03*", "", "0.828", "2.29 (0.979–5.35)", "1.91", "5.60E-02"], ["Tobacco smoking history (ever vs. never)", "−0.0557", "0.946 (0.637–1.4)", "−0.276", "7.82E-01", "", "", "", "", ""], ["Number pack years smoked", "−0.000552", "0.999 (0.993–1.01)", "−0.165", "8.69E-01", "", "", "", "", ""], ["Race (White vs. non-White)", "0.0557", "1.06 (0.703–1.59)", "0.268", "7.89E-01", "", "", "", "", ""], ["Ethnicity (Hispanic or Latino vs. non-Hispanic or Latino)", "0.291", "1.34 (0.495–3.62)", "0.574", "5.66E-01", "", "", "", "", ""], ["Tumor intermediate dimension", "0.328", "1.39 (0.84–2.29)", "1.28", "2.01E-01", "", "", "", "", ""], ["Radiation therapy (yes vs. no)", "0.707", "2.03 (1.42–2.89)", "3.92", "9.01E-05*", "", "0.432", "1.54 (0.829–2.86)", "1.37", "1.72E-01"], ["Additional pharmaceutical therapy (yes vs. no)", "0.27", "1.31 (0.914–1.88)", "1.47", "1.41E-01", "", "", "", "", ""], ["Additional radiation therapy (yes vs. no)", "0.16", "1.17 (0.825–1.67)", "0.89", "3.73E-01", "", "", "", "", ""], ["Location in lung parenchyma (central lung vs. peripheral lung)", "−0.0709", "0.932 (0.584–1.49)", "−0.298", "7.66E-01", "", "", "", "", ""], ["KRAS mutation (yes vs. no)", "−0.275", "0.759 (0.316–1.82)", "−0.616", "5.38E-01", "", "", "", "", ""], ["EGFR mutation (yes vs. no)", "0.483", "1.62 (1.06–2.49)", "2.21", "2.71E-02*", "", "0.277", "1.32 (0.812–2.14)", "1.12", "2.64E-01"], ["EML4-ALK mutation (yes vs. no)", "0.509", "1.66 (0.965–2.87)", "1.83", "6.72E-02", "", "", "", "", ""], ["Risk score", "0.853", "2.35 (1.74–3.16)", "5.63", "1.80E-08*", "", "0.727", "2.07 (1.22–3.52)", "2.68", "7.35E-03*"], ["GSE72094 (overall survival)&", "", "", "", "", "", "", "", "", ""], ["Gender (male vs. female)", "0.44", "1.55 (1.07–2.25)", "2.33", "1.98E-02*", "", "0.464", "1.59 (1.09–2.33)", "2.39", "1.67E-02*"], ["Age", "0.00696", "1.01 (0.988–1.03)", "0.702", "4.83E-01", "", "", "", "", ""], ["Race (White vs. non-White)", "−0.0694", "0.933 (0.38–2.29)", "−0.151", "8.80E-01", "", "", "", "", ""], ["Ethnicity (Hispanic or Latino vs. non-Hispanic or Latino)", "−0.642", "0.526 (0.0733–3.78)", "−0.638", "5.24E-01", "", "", "", "", ""], ["Tobacco smoking history (ever vs. never)", "0.314", "1.37 (0.597–3.14)", "0.741", "4.59E-01", "", "", "", "", ""], ["Tumor stage II (vs. stage I)", "0.758", "2.13 (1.32–3.44)", "3.11", "1.85E-03*", "", "0.708", "2.03 (1.25–3.28)", "2.88", "3.92E-03*"], ["Tumor stage III (vs. stage I)", "1.13", "3.09 (1.93–4.97)", "4.67", "3.00E-06*", "", "1.17", "3.22 (1.99–5.22)", "4.76", "1.91E-06*"], ["Tumor stage IV (vs. stage I)", "1.21", "3.35 (1.59–7.06)", "3.18", "1.48E-03*", "", "1.14", "3.13 (1.48–6.62)", "2.99", "2.80E-03*"], ["KRAS mutation (yes vs. no)", "0.376", "1.46 (1–2.12)", "1.97", "4.92E-02*", "", "0.157", "1.17 (0.796–1.72)", "0.799", "4.24E-01"], ["EGFR mutation (yes vs. no)", "−1.34", "0.262 (0.0965–0.71)", "−2.63", "8.49E-03*", "", "−0.926", "0.396 (0.143–1.1)", "−1.78", "7.52E-02"], ["STK11 mutation (yes vs. no)", "−0.0393", "0.961 (0.58–1.59)", "−0.153", "8.79E-01", "", "", "", "", ""], ["TP53 mutation (yes vs. no)", "0.211", "1.23 (0.82–1.86)", "1.01", "3.13E-01", "", "", "", "", ""], ["Risk score", "0.613", "1.85 (1.47–2.31)", "5.33", "1.00E-07*", "", "0.508", "1.66 (1.31–2.11)", "4.14", "3.54E-05*"], ["GSE68465 (overall survival)$", "", "", "", "", "", "", "", "", ""], ["Gender (male vs. female)", "0.33", "1.39 (1.07–1.8)", "2.5", "1.25E-02*", "", "0.324", "1.38 (1.05–1.83)", "2.27", "2.32E-02*"], ["Age", "0.0266", "1.03 (1.01–1.04)", "3.97", "7.16E-05*", "", "0.0357", "1.04 (1.02–1.05)", "4.93", "8.10E-07*"], ["Race (White vs. non-White)", "0.32", "1.38 (0.702–2.71)", "0.931", "3.52E-01", "", "", "", "", ""], ["Chemotherapy (yes vs. no)", "0.488", "1.63 (1.22–2.18)", "3.29", "9.99E-04*", "", "0.243", "1.28 (0.861–1.89)", "1.21", "2.25E-01"], ["Radiation therapy (yes vs. no)", "0.698", "2.01 (1.47–2.75)", "4.37", "1.26E-05*", "", "0.26", "1.3 (0.838–2)", "1.17", "2.43E-01"], ["T classification (T2 vs. T1)", "0.381", "1.46 (1.09–1.97)", "2.52", "1.18E-02*", "", "0.126", "1.13 (0.829–1.55)", "0.786", "4.32E-01"], ["T classification (T3 vs. T1)", "1.2", "3.31 (2.06–5.34)", "4.92", "8.78E-07*", "", "0.76", "2.14 (1.29–3.55)", "2.94", "3.27E-03*"], ["T classification (T4 vs. T1)", "1.45", "4.26 (2.17–8.34)", "4.22", "2.41E-05*", "", "1.06", "2.89 (1.36–6.13)", "2.77", "5.59E-03*"], ["N classification (N1 vs. N0)", "0.821", "2.27 (1.67–3.09)", "5.23", "1.74E-07*", "", "0.775", "2.17 (1.57–3)", "4.69", "2.74E-06*"], ["N classification (N2 vs. N0)", "1.36", "3.9 (2.77–5.48)", "7.82", "5.47E-15", "", "1.24", "3.45 (2.33–5.09)", "6.22", "5.08E-10*"], ["Tobacco smoking history (ever vs. never)", "0.22", "1.25 (0.79–1.96)", "0.946", "3.44E-01", "", "", "", "", ""], ["Risk score", "0.331", "1.39 (1.18–1.64)", "3.94", "8.17E-05*", "", "0.356", "1.43 (1.19–1.71)", "3.84", "1.22E-04*"]], "row_count": 67, "column_count": 10, "numeric_cells": 370, "header_rows": 2, "locator": "section[12]/table-wrap[1]#t4"}}], "gaps": ["asset:data:geo:GSE68465 not downloaded", "asset:data:geo:GSE68465 licence not read", "asset:data:geo:GSE72094 not downloaded", "asset:data:geo:GSE72094 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}, {"id": "method-2", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Cox regression"}}, {"id": "method-3", "family": "diagnostic_evaluation", "specific": "roc", "label": "Diagnostic test evaluation", "dsl_operations": ["confusion_counts", "roc_curve", "sensitivity_specificity", "solve_confusion_matrix", "classification_metrics", "published_precision_envelope"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["reference_standard_and_test"], "evidence": {"score": 0.7, "band": "medium", "quote": "ROC analysis"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["survival_km"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: kaplan_meier."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE72094", "GSE68465"], "resolved_accessions": ["GSE72094", "GSE68465"], "statements": ["The TCGA-LUAD dataset was chosen as the training cohort and downloaded from the GDC Xena Hub (https://gdc.xenahubs.net). Five hundred patients with LUAD in the TCGA-LUAD dataset who had both gene expression and survival data available were included in our research."], "basis": "The paper names GSE72094, GSE68465 in GEO database and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["survival_km"], "assets": ["source:pmid:34422970", "data:geo:GSE68465", "asset:table:pmid:34422970:1", "asset:table:pmid:34422970:2", "asset:table:pmid:34422970:3", "asset:table:pmid:34422970:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE68465"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T19:46:13Z", "independence": "single_reader"}, "evidence_check": {"method": null, "availability": null}, "calls": 3, "usage": {"prompt_tokens": 26836, "completion_tokens": 2616, "cached_tokens": 792}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:34422970", "type": "paper", "label": "pmid:34422970"}, {"id": "source:pmid:34422970", "type": "manuscript", "label": "PMID 34422970 full text"}, {"id": "data:geo:GSE68465", "type": "dataset", "label": "GEO GSE68465"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:34422970", "type": "paper", "label": "pmid:34422970"}, {"id": "source:pmid:34422970", "type": "manuscript", "label": "PMID 34422970 full text"}, {"id": "data:geo:GSE68465", "type": "dataset", "label": "GEO GSE68465"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-34422970", "type": "extraction", "used": ["source:pmid:34422970"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE68465", "type": "accession_resolution", "used": ["data:geo:GSE68465"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:34422970", "parent_hash": "sha256:4e059392ef9dc8043caa45f12c48a7a3059ff9797ce93d5df4ad04dd35b2095d", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:GSE68465 licence not read", "asset:data:geo:GSE68465 not downloaded", "asset:data:geo:GSE72094 licence not read", "asset:data:geo:GSE72094 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["survival_km"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.7, "evidence": ["Kaplan-Meier"], "order_basis": "analysis_only", "id": "assay:1"}]}